<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for pain with intrauterine device insertion - Lopez, LM - 2015 | Cochrane Library</title> <meta content="Interventions for pain with intrauterine device insertion - Lopez, LM - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007373.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for pain with intrauterine device insertion - Lopez, LM - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007373.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007373.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for pain with intrauterine device insertion" name="citation_title"/> <meta content="Laureen M Lopez" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="llopez@fhi360.org" name="citation_author_email"/> <meta content="Alissa Bernholc" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Yanwu Zeng" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Rebecca H Allen" name="citation_author"/> <meta content="Women and Infants Hospital" name="citation_author_institution"/> <meta content="Deborah Bartz" name="citation_author"/> <meta content="Brigham and Women's Hospital" name="citation_author_institution"/> <meta content="Paul A O'Brien" name="citation_author"/> <meta content="Central London Community Healthcare" name="citation_author_institution"/> <meta content="David Hubacher" name="citation_author"/> <meta content="FHI 360" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD007373.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/07/29" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007373.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007373.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007373.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Inflammatory Agents, Non‐Steroidal [therapeutic use]; Ibuprofen [therapeutic use]; Intrauterine Devices [*adverse effects]; Lidocaine [therapeutic use]; Misoprostol [therapeutic use]; Naproxen [therapeutic use]; Oxytocics [therapeutic use]; Pain [*drug therapy, prevention &amp; control]; Prilocaine [therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007373.pub3&amp;doi=10.1002/14651858.CD007373.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="gpg7sF9V";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007373\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007373\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007373.pub3",title:"Interventions for pain with intrauterine device insertion",firstPublishedDate:"Jul 29, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Fertility Regulation Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007373.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007373.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007373.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007373.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007373.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007373.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007373.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007373.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007373.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007373.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14353 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007373.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0088"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0021"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0022"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/appendices#CD007373-sec-0093"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/table_n/CD007373StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/table_n/CD007373StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for pain with intrauterine device insertion</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Laureen M Lopez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0003">Alissa Bernholc</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0004">Yanwu Zeng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0005">Rebecca H Allen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0006">Deborah Bartz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0007">Paul A O'Brien</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information#CD007373-cr-0008">David Hubacher</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information/en#CD007373-sec-0112">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 29 July 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007373.pub3">https://doi.org/10.1002/14651858.CD007373.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007373-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007373-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007373-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007373-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007373-abs-0001" lang="en"> <section id="CD007373-sec-0001"> <h3 class="title" id="CD007373-sec-0001">Background</h3> <p>Fear of pain during insertion of intrauterine contraception (IUC) is a barrier to use of this method. IUC includes copper‐containing intrauterine devices and levonorgestrel‐releasing intrauterine systems. Interventions for pain control during IUC insertion include non‐steroidal anti‐inflammatory drugs (NSAIDs), local cervical anesthetics, and cervical ripening agents such as misoprostol. </p> </section> <section id="CD007373-sec-0002"> <h3 class="title" id="CD007373-sec-0002">Objectives</h3> <p>To review randomized controlled trials (RCTs) of interventions for reducing IUC insertion‐related pain </p> </section> <section id="CD007373-sec-0003"> <h3 class="title" id="CD007373-sec-0003">Search methods</h3> <p>We searched for trials in CENTRAL, MEDLINE, EMBASE, POPLINE, ClinicalTrials.gov, and ICTRP. The most recent search was 22 June 2015. We examined reference lists of pertinent articles. For the initial review, we wrote to investigators to find other published or unpublished trials. </p> </section> <section id="CD007373-sec-0004"> <h3 class="title" id="CD007373-sec-0004">Selection criteria</h3> <p>We included RCTs that evaluated an intervention for preventing IUC insertion‐related pain. The comparison could have been a placebo, no intervention, or another active intervention. The primary outcomes were self‐reported pain at tenaculum placement, during IUC insertion, and after IUC insertion (up to six hours). </p> </section> <section id="CD007373-sec-0005"> <h3 class="title" id="CD007373-sec-0005">Data collection and analysis</h3> <p>Two authors extracted data from eligible trials. For dichotomous variables, we calculated the Mantel‐Haenszel odds ratio (OR) with 95% confidence interval (CI). For continuous variables, we computed the mean difference (MD) with 95% CI. In meta‐analysis of trials with different measurement scales, we used the standardized mean difference (SMD). </p> </section> <section id="CD007373-sec-0006"> <h3 class="title" id="CD007373-sec-0006">Main results</h3> <p>We included 33 trials with 5710 participants total; 29 were published from 2010 to 2015. Studies examined lidocaine, misoprostol, NSAIDs, and other interventions. Here we synthesize results from trials with sufficient outcome data and moderate‐ or high‐quality evidence. </p> <p>For lidocaine, meta‐analysis showed topical 2% gel had no effect on pain at tenaculum placement (two trials) or on pain during IUC insertion (three trials). Other formulations were effective compared with placebo in individual trials. Mean score for IUC‐insertion pain was lower with lidocaine and prilocaine cream (MD ‐1.96, 95% CI ‐3.00 to ‐0.92). Among nulliparous women, topical 4% formulation showed lower scores for IUC‐insertion pain assessed within 10 minutes (MD ‐15.90, 95% CI ‐22.77 to ‐9.03) and at 30 minutes later (MD ‐11.10, 95% CI ‐19.05 to ‐3.15). Among parous women, IUC‐insertion pain was lower with 10% spray (median 1.00 versus 3.00). Compared with no intervention, pain at tenaculum placement was lower with 1% paracervical block (median 12 versus 28). </p> <p>For misoprostol, meta‐analysis showed a higher mean score for IUC insertion compared with placebo (SMD 0.27, 95% CI 0.07 to 0.46; four studies). In meta‐analysis, cramping was more likely with misoprostol (OR 2.64, 95% CI 1.46 to 4.76; four studies). A trial with nulliparous women found a higher score for IUC‐insertion pain with misoprostol (median 46 versus 34). Pain before leaving the clinic was higher for misoprostol in two trials with nulliparous women (MD 7.60, 95% CI 6.48 to 8.72; medians 35.5 versus 20.5). In one trial with nulliparous women, moderate or severe pain at IUC insertion was less likely with misoprostol (OR 0.30, 95% CI 0.16 to 0.55). In the same trial, the misoprostol group was more likely to rate the experience favorably. Within two trials of misoprostol plus diclofenac, shivering, headache, or abdominal pain were more likely with misoprostol. Participants had no vaginal delivery. One trial showed the misoprostol group less likely to choose or recommend the treatment. </p> <p>Among multiparous women, mean score for IUC‐insertion pain was lower for tramadol 50 mg versus naproxen 550 mg (MD ‐0.63, 95% CI ‐0.94 to ‐0.32) and for naproxen versus placebo (MD ‐1.94, 95% CI ‐2.35 to ‐1.53). The naproxen group was less likely than the placebo group to report the insertion experience as unpleasant and not want the medication in the future. An older trial showed repeated doses of naproxen 300 mg led to lower pain scores at one hour (MD ‐1.04, 95% CI ‐1.67 to ‐0.41) and two hours (MD ‐0.98, 95% CI ‐1.64 to ‐0.32) after insertion. Most women were nulliparous and also had lidocaine paracervical block. </p> </section> <section id="CD007373-sec-0007"> <h3 class="title" id="CD007373-sec-0007">Authors' conclusions</h3> <p>Nearly all trials used modern IUC. Most effectiveness evidence was of moderate quality, having come from single trials. Lidocaine 2% gel, misoprostol, and most NSAIDs did not help reduce pain. Some lidocaine formulations, tramadol, and naproxen had some effect on reducing IUC insertion‐related pain in specific groups. The ineffective interventions do not need further research. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007373-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007373-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007373-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007373-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007373-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007373-abs-0003" lang="en"> <h3>Methods to reduce pain with insertion of intrauterine contraception</h3> <p>Fear of pain with insertion of intrauterine contraception (IUC) may cause women to avoid using this very effective method of birth control. IUC includes devices with copper and with the hormone levonorgestrel. Researchers have studied many ways of reducing pain with IUC insertion. These include drugs that lessen uterine cramps, soften and open the cervix (uterus opening), or numb the cervix. </p> <p>We reviewed randomized trials of reducing pain during IUC insertion through 22 June 2015. We found 33 studies with a total of 5710 women. Most were recent trials. Methods tested were nonsteroidal anti‐inflammatory drugs (NSAIDs), lidocaine, misoprostol, and other treatments. Lidocaine 2% gel had no effect on pain during IUC insertion (three trials) or pain with tenaculum (type of forceps) placement (two trials). Other types of lidocaine showed some effect. Pain score for IUC insertion was lower with a lidocaine and prilocaine cream and with 10% lidocaine spray. With 4% lidocaine gel, pain scores were lower shortly after IUC insertion. With 1% lidocaine injection, pain score at tenaculum placement was lower compared with no intervention. </p> <p>With four misoprostol trials, the pain score with IUC insertion was higher for misoprostol versus placebo ('dummy' treatment). Two other trials showed higher pain scores with misoprostol versus placebo either at IUC insertion or after. However, another study showed the misoprostol group had less serious IUC‐insertion pain. Also, the misoprostol group rated the insertion more favorably. In analysis of four trials, cramping was more likely with misoprostol versus placebo. Within two other trials, the misoprostol group was more likely to have shivering, headache, or abdominal pain. In one study, the misoprostol group was less likely to choose the treatment again or recommend it. </p> <p>Pain score during IUC insertion was lower for the opioid tramadol versus naproxen. In the same trial, pain was lower for naproxen versus placebo. The naproxen group was less likely than the placebo group to rate the experience as unpleasant and not want the treatment in the future. In another trial, women with several naproxen doses had lower pain scores after IUC insertion than the placebo group. </p> <p>Overall, the effectiveness results were of moderate quality, having come from single studies. Trials of lidocaine, tramadol and naproxen showed some effect on reducing pain from IUC insertion. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007373-sec-0088" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007373-sec-0088"></div> <h3 class="title" id="CD007373-sec-0089">Implications for practice</h3> <section id="CD007373-sec-0089"> <p>A few treatments made a difference in pain control. Of the NSAIDs, naproxen may decrease pain during IUC insertion among parous women (550 mg) and in the first hours afterward in nulliparous women (300 mg; two separate doses). Most trials show no benefit of ibuprofen. The opioid tramadol (50 mg) may reduce pain during insertion among parous women but only slightly more than naproxen does. Misoprostol did not help with pain; it may even increase pain and cause more side effects. Lidocaine 2% gel showed no effect on pain with tenaculum placement or during IUC insertion. Some other lidocaine formulations may lessen pain during IUC insertion and shortly thereafter. These include 4% topical gel studied in nulliparous women, 10% spray examined in parous women, lidocaine and prilocaine cream, and 1% paracervical block. The wait time between application and intervention for these medications to act ranged from three to seven minutes. Practitioners still need better interventions than those generally used. </p> <p>Two recent papers discuss the evidence regarding pain management for practical purposes. <a href="./references#CD007373-bbs2-0064" title="Kass‐WolffJH , FisherJE . Evidence‐based pain management for endometrial biopsies and IUD insertions. Nurse Practitioner2014;39(3):43‐50. ">Kass‐Wolff 2014</a> examined interventions for pain related to endometrial biopsies and IUC insertion. The intent was to inform advance practice nurses of the available evidence. <a href="./references#CD007373-bbs2-0053" title="BahamondesL , MansourD , FialaC , KaunitzAM , Gemzell‐DanielssonK . Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives. Journal of Family Planning and Reproductive Health Care2014;40(1):54‐60. ">Bahamondes 2014</a> focused on pain related to IUC insertion with the intent of providing recommendations for practice. The researchers reviewed pharmacological interventions, and addressed insertion methods and pre‐insertion counseling. </p> </section> <h3 class="title" id="CD007373-sec-0090">Implications for research</h3> <section id="CD007373-sec-0090"> <p>From 2010 to 2015, 29 RCTs were completed that evaluated interventions for pain with IUC insertion. While most were high‐quality trials, we downgraded the evidence quality if the effectiveness data came from a single trial. Future research may change the estimate. The studies tested several NSAIDs, various lidocaine formulations and administration methods, misoprostol, and other interventions. Most trials used the modern levonorgestrel‐releasing intrauterine system (LNG‐IUS) or the copper T 380A IUD. The studies measured pain at tenaculum placement as well as pain during and after IUD insertion. We considered most evidence of effectiveness to be of moderate quality, having come from single studies. Several interventions had no effect on pain; these included lidocaine 2% gel, misoprostol, and most NSAIDs. Therefore, many interventions do not require further research. </p> <p>A few interventions helped reduce pain among specific groups of women, e.g., parous or nulliparous women. Those interventions were naproxen 550 mg, tramadol 50 mg, and some lidocaine formulations (i.e., lidocaine and prilocaine cream, short‐acting 4% gel, 10% spray, and 1% paracervical block). Trials with participants of differing parity would help determine if results are consistent. Use of the same scales and measurement times across trials would facilitate interpretation of results. To make the procedure acceptable to women, we need a greater understanding of how much pain reduction women expect and want from these interventions. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007373-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007373-sec-0015"></div> <div class="table" id="CD007373-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: lidocaine 2% gel</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Lidocaine 2% gel compared with placebo for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: lidocaine 2% gel, topical</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on parity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at tenaculum placement</b> (10 cm or 100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.03 (‐0.25 to 0.18)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No limitation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10 cm or 100 mm VAS) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.02 (‐0.21 to 0.18)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>409<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No limitation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; SMD: Standardized mean difference; CI: Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD007373-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: other lidocaine</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Lidocaine formulations for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: lidocaine formulations (see Notes)</b> </p> <p><b>Comparison: see Notes</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on intervention<br/> (parity specification)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at tenaculum placement</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><i>Median (1st, 3rd quartiles):</i> </p> <p>12 (4, 27) vs 28 (14.5, 40.5)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50<br/> (<a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 1% paracervical block vs no intervention</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion</b> (10 cm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.96 (95% CI ‐3.00 to ‐0.92)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92<br/> (<a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) vs placebo cream</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion</b> (10 cm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>1.00 (0 to 6) vs 3.00 (0 to 7)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200<br/> (<a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 10% spray vs saline placebo</p> <p>(parous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion (within 10 min)</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐15.90 (95% CI ‐22.77 to ‐9.03)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209</p> <p>(<a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 4% short‐acting gel vs placebo gel</p> <p>(nulliparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at 30 min post‐insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐11.10 (95% CI ‐19.05 to ‐3.15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(<a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 4% short‐acting gel vs placebo gel</p> <p>(nulliparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; MD: Mean difference; CI: Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007373-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings: naproxen or tramadol</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Naproxen or tramadol for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: naproxen or tramadol</b> </p> <p><b>Comparison: see Notes</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on intervention<br/> (parity)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.63 (‐0.94 to ‐0.32)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tramadol 50 mg vs naproxen 550 mg</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.94 (‐2.35 to ‐1.53)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction</b> : <b>insertion experience was unpleasant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.02 (0.01 to 0.09)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction</b> : <b>would not want treatment in future</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.02 (0.00 to 0.08)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score 1 hour after IUC insertion</b> (5‐point scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.04 (‐1.67 to ‐0.41)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>(<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (4 doses) vs placebo; both had paracervical block</p> <p>(48 nulliparous/50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score 2 hours after IUC insertion</b> (5‐point scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.98 (‐1.64 to ‐0.32)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41</p> <p>(<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naproxen 300 mg (4 doses) vs placebo; both had paracervical block</p> <p>(48 nulliparous/50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; MD: Mean difference; CI: Confidence interval: OR: Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007373-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings: misoprostol 400 µg</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Misoprostol 400 µg compared with placebo for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: misoprostol 400 µg</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on administration<br/> (parity)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.27 (95% CI 0.07 to 0.46)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal<br/> (parity varied by trial) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: cramping</b> (before IUC insertion) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>OR 2.64 (95% CI 1.46 to 4.76)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>466<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal<br/> (parity varied by trial) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate to severe pain at IUC insertion</b> (dichotomous) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.30 (95% CI 0.16 to 0.55)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179<br/> (<a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> <p>(nulligravida)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Satisfaction: experience was</b> </p> <p><b>slightly or not disagreeable</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>OR 4.34 (95% CI 2.32 to 8.12)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>179<br/> (<a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> <p>(nulligravida)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at IUC insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>46 (11 to 92) vs 34 (0 to 90)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73</p> <p>(<a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> <p>(no pregnancy &gt;= 20 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score before leaving clinic</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>35.5 (1 to 100) vs 20.5 (0 to 86)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73</p> <p>(<a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> <p>(no pregnancy &gt;= 20 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for highest level before leaving clinic</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.60 (95% CI 6.48 to 8.72)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105<br/> (<a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> <p>(no pregnancy &gt;= 14 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; SMD: Standardized mean difference; MD: Mean difference; CI: Confidence interval; OR<b>:</b> Odds Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD007373-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings: misoprostol 400 µg + diclofenac</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Misoprostol 400 µg + diclofenac compared with diclofenac for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: misoprostol 400 µg (sublingual) + diclofenac 100 mg</b> </p> <p><b>Comparison: diclofenac 100 mg</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on parity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.68 (1.23 to 26.19)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: abdominal pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 3.93 (1.41 to 10.97)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>230</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: shivering</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.48 (1.41 to 21.33)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79</p> <p>(<a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction: would choose treatment again</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.30 (0.14 to 0.65)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction: would recommend treatment to friend</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.36 (0.16 to 0.81)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: CI: Confidence interval; OR<b>:</b> Odds Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007373-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007373-sec-0016"></div> <section id="CD007373-sec-0017"> <h3 class="title" id="CD007373-sec-0017">Description of the condition</h3> <p>Intrauterine contraception (IUC) provides long‐term, reversible contraception equal in efficacy to tubal sterilization (<a href="./references#CD007373-bbs2-0060" title="GrimesDA , MishellDR . Intrauterine contraception as an alternative to interval tubal sterilization. Contraception2008;77(1):6‐9. ">Grimes 2008</a>). IUC includes copper‐containing intrauterine devices (IUDs) and levonorgestrel‐releasing intrauterine systems (LNG‐IUS). The term 'IUD' is often used to include both types. Depending on the country, the use of IUDs worldwide ranges from 2% to 75%. On average, 15% of reproductive‐aged women in "developing regions" and 9% in "developed regions" use IUDs (<a href="./references#CD007373-bbs2-0073" title="United Nations PopulationDivision . World Contraceptive Patterns 2013. www.un.org/en/development/desa/population/publications/family/contraceptive‐wallchart‐2013.shtml (accessed 11 February 2015). ">UN 2013</a>). Increasing the number of women using IUC is an important public health goal. IUDs are considered appropriate for most women, including nulliparous women and adolescents (<a href="./references#CD007373-bbs2-0055" title="Committee on Adolescent Health Care, Long‐Acting Reversible Contraception Working Group. American College of Obstetricians Gynecologists Committee Opinion no. 539: Adolescents and long‐acting reversible contraception: implants and intrauterine devices. Obstetrics and Gynecology2012;120(4):983‐8. ">Comm Adolescent Health 2012</a>; <a href="./references#CD007373-bbs2-0067" title="OttMA , SucatoGS , Committee on Adolescence. Contraception for adolescents. Pediatrics2014;134(4):e1257‐81. ">Ott 2014</a>). One barrier to IUC is the fear of pain during insertion (<a href="./references#CD007373-bbs2-0052" title="AskerC , Stokes‐LampardH , BeavanJ , WilsonS . What is it about intrauterine devices that women find unacceptable? Factors that make women non‐users: a qualitative study. Journal of Family Planning and Reproductive Health Care2006;32(2):89‐94. ">Asker 2006</a>). Components of the insertion procedure that may cause pain include the application of the tenaculum to the cervix to stabilize the uterus and provide traction for straightening the cervical canal, passing the uterine sound, advancing the inserter tube through the cervix, and irritation of the endometrial cavity when the device is deployed. Cervical pain is mediated by S2 to S4 parasympathetic nerves, and the T10 to L1 sympathetic fibers innervate the uterine fundus. While some IUDs are inserted postpartum or postabortal, most are inserted more than four weeks after pregnancy as a clinic‐based procedure. The levels of pain that women experience during IUD insertion vary in published reports. Most women experience mild to moderate discomfort during IUD insertion. Rarely, the pain is severe and associated with nausea and weakness. Pain may persist for a few days after insertion. Predictors of pain during IUC insertion include nulliparity, age greater than 30 years, a longer interval since last pregnancy or menses, history of dysmenorrhea, and not currently breastfeeding (<a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a>; <a href="./references#CD007373-bbs2-0063" title="KaislasuoJ , HeikinheimoO , LähteenmäkiP , SuhonenS . Predicting painful or difficult intrauterine device insertion in nulligravid women. Obstetrics and Gynecology2014;124(2 Pt 1):345‐53. ">Kaislasuo 2014</a>). Psychosocial factors, such as expected pain, also influence the pain perceived by women undergoing the procedure (<a href="./references#CD007373-bbs2-0058" title="GoldstuckND , MathewsML . A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device. Clinical Reproduction and Fertility1985;3(1):65‐71. ">Goldstuck 1985</a>; <a href="./references#CD007373-bbs2-0066" title="MurtyJ . Use and effectiveness of oral analgesia when fitting an intrauterine device. Journal of Family Planning and Reproductive Health Care2003;29(3):150‐1. ">Murty 2003</a>). </p> </section> <section id="CD007373-sec-0018"> <h3 class="title" id="CD007373-sec-0018">Description of the intervention</h3> <p>Pharmacological methods of pain control used for IUC insertion commonly include non‐steroidal anti‐inflammatory drugs (NSAIDs), anxiolytics, opioids, and local anesthetics in the form of intracervical gel, cervical and paracervical block, and intrauterine instillation. A survey of UK physicians found a wide variation in the use of analgesia or anesthesia for IUC insertions from no routine use to always using prophylactic NSAIDs or 2% lidocaine gel intracervically during the procedure (<a href="./references#CD007373-bbs2-0071" title="TolcherR . Intrauterine techniques: contentious or consensus opinion?. Journal of Family Planning and Reproductive Health Care2003;29(1):21‐4. ">Tolcher 2003</a>). Other interventions to ease IUC insertion include the use of prostaglandins or nitric oxide donors such as nitroprusside and nitroglycerin. </p> </section> <section id="CD007373-sec-0019"> <h3 class="title" id="CD007373-sec-0019">How the intervention might work</h3> <p>Local anesthetics that are administered topically or through injection may decrease cervical pain by blocking nerve fibers. Anxiolytics reduce pre‐insertion anxiety and may lead to decreased pain perception by the woman (<a href="./references#CD007373-bbs2-0066" title="MurtyJ . Use and effectiveness of oral analgesia when fitting an intrauterine device. Journal of Family Planning and Reproductive Health Care2003;29(3):150‐1. ">Murty 2003</a>). NSAIDs have been shown to reduce pain associated with IUD use (<a href="./references#CD007373-bbs2-0059" title="GrimesDA , HubacherD , LopezLM , SchulzKF . Non‐steroidal anti‐inflammatory drugs for heavy bleeding or pain associated with IUD use. Cochrane Database of Systematic Reviews2006;4:CD006034. ">Grimes 2006</a>). In the context of IUD insertion, NSAIDs and opioids may reduce cervical or uterine pain. Misoprostol, a prostaglandin E1 analogue, may decrease pain by dilating and softening the cervix prior to insertion (<a href="./references#CD007373-bbs2-0057" title="GoldbergAB , CarusiDA , MeckstrothKR . Misoprostol in gynecology. Current Women's Health Reports2003;3(6):475‐83. ">Goldberg 2003</a>). Nitric oxide donors are smooth muscle relaxants that may also soften the cervix but without the uterine cramping found with misoprostol (<a href="./references#CD007373-bbs2-0070" title="ThomsonAJ , LunanCB , CameronAD , CameronIT , GreerIA , NormanJE . Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial. British Journal of Obstetrics and Gynaecology1997;104(9):1054‐1057. ">Thomson 1997</a>; <a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>). </p> </section> <section id="CD007373-sec-0020"> <h3 class="title" id="CD007373-sec-0020">Why it is important to do this review</h3> <p>Pain at insertion of an IUD can be distressing and may deter women from using the method. Since the publication of our initial review in 2009 that called for more research, numerous trials have examined various interventions for pain with IUD insertion. This review evaluates both prophylactic and procedural interventions to reduce pain. Determining the optimal method for reducing pain during IUD insertion will benefit women and may increase the uptake of IUDs as a contraceptive method. Alternatively, ineffective interventions may only increase costs and delay initiation of the insertion procedure. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007373-sec-0021" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007373-sec-0021"></div> <p>To review randomized controlled trials (RCTs) of interventions for reducing IUC insertion‐related pain </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007373-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007373-sec-0022"></div> <section id="CD007373-sec-0023"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007373-sec-0024"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials in any language that evaluated an intervention for preventing IUC insertion‐related pain. The intervention could be compared with a placebo or another active intervention. </p> </section> <section id="CD007373-sec-0025"> <h4 class="title">Types of participants</h4> <p>Women having any type of IUC inserted</p> </section> <section id="CD007373-sec-0026"> <h4 class="title">Types of interventions</h4> <p>We included any pharmacological or other intervention administered prior to, or during, IUC insertion in order to reduce pain at the time of insertion and up to six hours afterward. </p> </section> <section id="CD007373-sec-0027"> <h4 class="title">Types of outcome measures</h4> <section id="CD007373-sec-0028"> <h5 class="title">Primary outcomes</h5> <p>For this review, the primary outcomes were self‐reported pain scores related to IUC insertion: at tenaculum placement, during IUC insertion, and after IUC insertion (up to six hours). The trials may have had a different primary outcome, such as ease of insertion for the provider. </p> </section> <section id="CD007373-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p>Side effects, adverse events, and participant satisfaction</p> </section> </section> </section> <section id="CD007373-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007373-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched for trials until 22 June 2015. Databases included the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (PubMed), EMBASE, POPLINE, ClinicalTrials.gov and WHO ICTRP. Strategies for this version are shown in <a href="./appendices#CD007373-sec-0094">Appendix 1</a>. The search strategies for the initial review are shown in <a href="./appendices#CD007373-sec-0101">Appendix 2</a>. </p> </section> <section id="CD007373-sec-0032"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved titles and relevant review articles for additional studies. For the initial review, we wrote to investigators of published trials to solicit information regarding other published or unpublished trials that may have been missed in our initial search. </p> </section> </section> <section id="CD007373-sec-0033"> <h3 class="title" id="CD007373-sec-0033">Data collection and analysis</h3> <section id="CD007373-sec-0034"> <h4 class="title">Selection of studies</h4> <p>We assessed all titles and abstracts identified during the literature searches for potential eligibility. </p> </section> <section id="CD007373-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Two authors independently assessed and extracted data from the studies. We resolved any discrepancies or disagreements through discussion or a third author if needed. One author entered data into Review Manager 5 (<a href="./references#CD007373-bbs2-0069" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and a second confirmed correct data entry. We list the specifics tasks by author in <a href="#CD007373-sec-0109">Contributions of authors</a>. </p> </section> <section id="CD007373-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We examined the trial methodology according to recommended guidelines (<a href="./references#CD007373-bbs2-0062" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org (accessed 25 March 2014). ">Higgins 2011</a>). Factors that we considered for potential bias were study design, randomization process, allocation concealment, blinding, early discontinuation and loss to follow‐up rates. </p> </section> <section id="CD007373-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous variables, we computed the mean difference (MD) with 95% confidence interval (CI). If trials in meta‐analysis used different measurement scales, we used the standardized mean difference (SMD). RevMan uses the inverse variance approach. For dichotomous outcomes, we calculated the Mantel‐Haenszel odds ratio (OR) with 95% CI. In meta‐analysis, we used a random‐effects model. When a comparison includes only one study, fixed and random effects give the same result; no heterogeneity exists. Where the trial report provided only the medians and ranges, we present the data as provided by the investigators. </p> </section> <section id="CD007373-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial investigators as needed to supplement published information.</p> </section> <section id="CD007373-sec-0039"> <h4 class="title">Data synthesis</h4> <p>We applied principles from GRADE to assess the evidence quality and address confidence in the effect estimates (<a href="./references#CD007373-bbs2-0054" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. ">Balshem 2011</a>; <a href="./references#CD007373-bbs2-0062" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org (accessed 25 March 2014). ">Higgins 2011</a>). When a meta‐analysis is not viable due to varied interventions, a 'Summary of findings' table is not feasible. Therefore, not every trial or outcome is part of a formal GRADE assessment with an evidence profile and 'Summary of findings' table (<a href="./references#CD007373-bbs2-0061" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. ">Guyatt 2011</a>). </p> <p>Our assessment of evidence quality, which could be high, moderate, low, or very low, was based on the evidence from the individual studies. We considered the evidence from RCTs to be high quality initially, then downgraded as follows: 1) moderate quality if risk of bias (RoB) is high for one factor assessed or unclear for two; 2) low quality if RoB is high for two items or if high and unclear risk totals three; 3) very low if RoB is high for three factors or if high and unclear risk totals at least four. Follow‐up was less an issue for this review, since the primary outcomes of interest were measured on the procedure day. </p> <p>For the 'Summary of findings' tables, we downgraded one level if the evidence came from only one trial. We could not examine consistency across trials with only one study. Further research may change the estimate due to having a different population, intervention, or outcome measure. Examples include nulliparous women versus both parous and nulliparous women, different timing or application of the intervention, and different timing or assessment for the pain outcome. </p> </section> <section id="CD007373-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>We synthesized results from trials with sufficient outcome data and evidence of moderate or high quality. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007373-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007373-sec-0041"></div> <section id="CD007373-sec-0042"> <h3 class="title">Description of studies</h3> <section id="CD007373-sec-0043"> <h4 class="title">Results of the search</h4> <p>For the initial review in 2009, the search strategy yielded 349 articles. Four randomized controlled trials met the inclusion criteria for the review. </p> <p>For the 2015 version, the database searches produced 102 unduplicated citations (<a href="#CD007373-fig-0001">Figure 1</a>). We had removed 51 duplicates, either electronically or by hand. With six items identified from other sources, the total of unduplicated references was 108. After discarding 65 references, we reviewed the text of 43 articles or abstracts (primary and secondary). We added 29 new trials (<a href="./references#CD007373-bbs1-0001" title="">Included studies</a>): 27 full‐text primary reports plus two primary conference abstracts, both of which also had listings in a clinical trial register. For secondary reports, we included four full‐text articles and seven conference abstracts, some of which led us to the full‐text reports. We excluded two primary reports. </p> <div class="figure" id="CD007373-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD007373-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We categorized four trials as <a href="./references#CD007373-bbs1-0003" title="">Studies awaiting classification</a>: two with manuscripts reportedly in progress; one with no current information; and one with a conference abstract identified while this manuscript was under peer review. Also while under peer review, we identified conference abstracts from trials that examined alternatives to the standard tenaculum. We did not include them, because we had not searched for such studies and may only have seen a select sample. For the next update, we will consider whether to expand the search strategy with the terminology for that type of intervention. </p> <p>From recent clinical trial registers, we obtained 95 unduplicated trials. Two led us to primary reports included above. Three trials are <a href="./references#CD007373-bbs1-0004" title="">Ongoing studies</a>. We excluded two listings for trials that never started. The remaining listings were not relevant or represented completed trials that were already included. </p> </section> <section id="CD007373-sec-0044"> <h4 class="title">Included studies</h4> <p>We identified 33 trials that met our eligibility criteria, after adding 29 new studies to the original four. The trials had a total of 5710 participants, with a mean of 178 and the median at 95. The number of participants in each trial ranged from 24 to 2019: 18 trials had fewer than 100 participants, 14 had from 100 to 300 women, and one had 2019 participants. The reports were published from 1974 to 2015, with 29 published from 2010 to 2015. The trials were conducted in Eastern and Western Europe, the Middle East, South America, and the USA. Of the 33 trials, 7 evaluated non‐steroidal anti‐inflammatory drugs (NSAIDs), 12 examined lidocaine (one used an NSAID for comparison), 10 studied misoprostol, and 5 evaluated other interventions (one used NSAID as a comparison as well as placebo). </p> <p><a href="#CD007373-tbl-0006">Table 1</a> summarizes the experimental and comparison interventions for the 33 trials, along with the delivery method and timing. Additional trial details are given in <a href="./references#CD007373-sec-0117" title="">Characteristics of included studies</a>. </p> <div class="table" id="CD007373-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intervention summary</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Timing before procedure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Parity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg x 4 doses (+ paracervical block, 1% lidocaine, 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo (+ paracervical block, 1% lidocaine, 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Previous night and 1.5 h prior;<br/> 2 and 6 h after </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(96% nulliparous)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 4 h<br/> (also 4 to 6 h after) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 to 45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(Requesting abortion)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% gel (amount unspecified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lubricant gel or<br/> no intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 1 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>prior to uterine sounding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each, via syringe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomization stratified by parity</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo cream</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab on cervix and cervical opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No analgesia (no intervention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline or no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min (lidocaine); 1 h (ibuprofen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous or no vaginal delivery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean delivery only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pregnancy &gt; 19 6/7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 8 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pregnancy &gt; 13 6/7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulligravida</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>immediately prior</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 to 40 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 min (also during)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bladder emptying delayed (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bladder emptying immediate (before IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Water 1L, orally, 1 h before appointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>No full report; sources included conference abstract and clinical trial listing </p> </div> </div> <p>Seven trials examined NSAIDs, i.e., naproxen, ibuprofen, and ketorolac. For naproxen, the oral doses were 300 mg (four times) (<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) and 550 mg (<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>). Oral doses for ibuprofen were 400 mg (<a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a>), 600 mg (<a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a>) and 800 mg (<a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a>; <a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a>). The ketorolac dose was 30 mg by intramuscular injection (<a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a>). In addition, a lidocaine trial used ibuprofen as the comparator (<a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a>); results are presented with the other lidocaine trials. </p> <p>Twelve trials examined the effects of various lidocaine formulations. These include 2% gel (<a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a>; <a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a>; <a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a>; <a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a>; <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>), 4% gel (<a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>), a cream containing lidocaine and prilocaine (<a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a>), 2% solution for infusion (<a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a>), 10% spray (<a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a>), 1% paracervical block (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>; <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>), and 2% intracervical block (<a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a>). </p> <p>Ten trials evaluated misoprostol 400 µg. Administration was sublingual (<a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a>; <a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>; <a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>), buccal (<a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a>; <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>; <a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>), vaginal (<a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a>; <a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>), or either vaginal or buccal (<a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a>; <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>). Five of these trials were part of a prospective meta‐analysis as described in <a href="./references#CD007373-bbs2-0072" title="TurokDK , EspeyE , EdelmanAB , LotkePS , LathropEH , TealSB , et al. The methodology for developing a prospective meta‐analysis in the family planning community. Trials2011;12:104. ">Turok 2011</a> (<a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a>; <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>; <a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>; <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a>; <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>). </p> <p>Five trials studied other interventions. Two examined nitric oxide donors, i.e., nitroprusside gel 1% (<a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>) and nitroglycerin ointment 0.5 mg (<a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a>). Others studied tramadol 50 mg and naproxen (<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>), delayed bladder emptying (<a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a>), and lavender essence (<a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a>). </p> </section> <section id="CD007373-sec-0045"> <h4 class="title">Excluded studies</h4> <p>We excluded 10 studies. Some lacked randomization (<a href="./references#CD007373-bbs2-0035" title="HepburnS . Method of local anesthesia for IUD insertion. Contraceptive Delivery Systems1980;1(4):371‐82. ">Hepburn 1980</a>; <a href="./references#CD007373-bbs2-0043" title="ThieryM . Pain relief at insertion and removal of an IUD: a simplified technique for paracervical block. Advances in Contraception1985;1(2):167‐70. ">Thiery 1985</a>); one used alternate assignment (<a href="./references#CD007373-bbs2-0039" title="NewtonJR , ReadingAE . The effects of psychological preparation on pain at intrauterine device insertion. Contraception1977;16(5):523‐32. ">Newton 1977</a>) and another assigned by date of birth (<a href="./references#CD007373-bbs2-0040" title="OlotoEJ , BromhamDR , MurtyJA . Pain and discomfort perception at IUD insertion‐‐effect of short‐duration, low‐volume, intracervical application of two percent lignocaine gel (Instillagel™)‐‐a preliminary study. British Journal of Family Planning1997;22(4):177‐80. ">Oloto 1997</a>). One report was a review article rather than intervention study (<a href="./references#CD007373-bbs2-0036" title="HollingworthB . Pain control during insertion of intrauterine device. British Journal of Family Planning1995;21(3):102‐3. ">Hollingworth 1995</a>). Two RCTs lacked our primary outcomes (<a href="./references#CD007373-bbs2-0034" title="GoldstuckND . Treatment of pain following IUD insertion with meptazinol‐a new centrally acting analgesic. Contraceptive Delivery Systems: An International Journal1983;4(1):33‐7. ">Goldstuck 1983</a>; <a href="./references#CD007373-bbs2-0037" title="JafariA , SayyahiM , TorkashvandR , PiryaeiH . Effect of vitamin B1 on pain after insertion of intrauterine device [article in Persian]. Journal of Babol University of Medical Sciences2014;16(3):13‐20. ">Jafari 2014</a>). For another study, the analysis did not appear to account for clustering effects (<a href="./references#CD007373-bbs2-0038" title="Mirmohamad AlieiM , KhazaieF , RahnamaP , RahimikianF , ModarresM , BekhradiR , et al. Effect of lavender on pain during insertion of intrauterine device: A clinical trial [article in Persian]. Journal of Babol University of Medical Sciences2013;15(4):93‐9. MirmohammadaliAM . Effect of lavender essential oil on anxiety and pain during insertion of intrauterine device. apps.who.int/trialsearch/trial.aspx?trialid=IRCT201209266206N4 (accessed 29 July 2014). [IRCT201209266206N4] ">Mirmohamad Aliei 2013</a>). Lastly, two trials never started (<a href="./references#CD007373-bbs2-0041" title="StephensonJ . Does topical anaesthetic gel reduce pain/discomfort during intrauterine device (IUD)/intrauterine system (IUD) insertion? A randomised, placebo‐controlled, double‐blind trial. www.controlled‐trials.com/ISRCTN83819888 (accessed 23 September 2014). ">Stephenson 2010</a>; <a href="./references#CD007373-bbs2-0042" title="TealS . IUD insertion in nulliparous women. clinicaltrials.gov/show/NCT01422226 (accessed 19 August 2014). ">Teal 2012</a>). </p> </section> </section> <section id="CD007373-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>Details for each study are shown in <a href="./references#CD007373-sec-0117" title="">Characteristics of included studies</a>. <a href="#CD007373-fig-0002">Figure 2</a> shows the overall risk of bias for evidence in this review. Risk of bias by trial can be seen in <a href="#CD007373-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007373-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about risk of bias as percentages across all 33 included studies" data-id="CD007373-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about risk of bias as percentages across all 33 included studies </p> </div> </div> </div> <div class="figure" id="CD007373-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about risk of bias for each included study" data-id="CD007373-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about risk of bias for each included study </p> </div> </div> </div> <section id="CD007373-sec-0047"> <h4 class="title">Allocation</h4> <p>Most included trials mentioned some type of computer‐generated randomization scheme and many also noted block size. Those lacking information were two conference abstracts (<a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a>; <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>) and one full report (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>). Similarly, most trials reported adequate allocation concealment, such as pharmacy‐blinding packages or sequentially numbered, sealed, opaque envelopes. The exceptions were the two abstracts and one report noted above, an older report (<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) and two recent trials (<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>; <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>). </p> </section> <section id="CD007373-sec-0048"> <h4 class="title">Blinding</h4> <p>Three studies did not appear to use any blinding (<a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a>; <a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>; <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>). The others reported some blinding, e.g., participants and providers, and some mentioned research staff or the analyst. </p> </section> <section id="CD007373-sec-0049"> <h4 class="title">Incomplete outcome data</h4> <p>Loss to follow‐up was a minor issue for the primary outcomes in this review. The main outcome of pain with IUD insertion was assessed during or immediately after the procedure. However, the assessment of pain up to six hours after the procedure could involve losses, as could side effect or satisfaction data. Loss data were unavailable from the conference abstracts (<a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a>; <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>). </p> </section> </section> <section id="CD007373-sec-0050"> <h3 class="title" id="CD007373-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD007373-tbl-0001"><b>Summary of findings for the main comparison</b> Summary of findings: lidocaine 2% gel</a>; <a href="./full#CD007373-tbl-0002"><b>Summary of findings 2</b> Summary of findings: other lidocaine</a>; <a href="./full#CD007373-tbl-0003"><b>Summary of findings 3</b> Summary of findings: naproxen or tramadol</a>; <a href="./full#CD007373-tbl-0004"><b>Summary of findings 4</b> Summary of findings: misoprostol 400 µg</a>; <a href="./full#CD007373-tbl-0005"><b>Summary of findings 5</b> Summary of findings: misoprostol 400 µg + diclofenac</a> </p> <p>Pain data for each study are summarized in <a href="#CD007373-tbl-0007">Table 2</a>, which also includes sample sizes. Most trials assessed pain level using a visual analog scale (VAS), e.g., 10 cm or 10 points or 100 mm. Specifics are given below. Data on satisfaction and side effects are summarized in <a href="#CD007373-tbl-0008">Table 3</a>. </p> <div class="table" id="CD007373-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome summary: pain</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total N</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at tenaculum placement</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain during IUC insertion</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain after IUC insertion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (x 4 doses) + paracervical block (1% lidocaine 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen &lt; placebo (1 h, 2 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (4 to 6 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac &lt; placebo (5 min, 15 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (global, visit end)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (within 10 min)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (30 min);</p> <p>NS (1 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA &lt; placebo (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo<br/> or control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo or control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo or control (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (2 h, 6 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo (before clinic departure)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (before clinic discharge)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo (before leaving clinic)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (30 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (30 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol &lt; naproxen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Delayed bladder emptying (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral (water 1 L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>NS = no significant difference between study arms<br/> <sup>b</sup>Excluded from sensitivity analysis due to insufficient outcome data or low quality evidence </p> </div> </div> <div class="table" id="CD007373-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome summary: side effects and satisfaction</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects or adverse events</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction or acceptability</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unsatisfied: naproxen &lt; placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (x 4 doses) + paracervical block (1% lidocaine 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL Topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shivering: misoprostol &gt; placebo;<br/> Other: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Headache or abdominal pain: misoprostol &gt; placebo;<br/> Other: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Choose again or recommend to friend: misoprostol &lt; control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with pain control: NS;<br/> Satisfaction with procedure: nitroprusside &lt; placebo </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with pain control or procedure: NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Delayed bladder emptying (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral (water 1 L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>NA = not available (assessed but not reported, or provided insufficient data)<br/> <sup>b</sup>Excluded from sensitivity analysis due to low quality evidence<br/> <sup>c</sup>NS = no significant difference between study arms </p> </div> </div> <section id="CD007373-sec-0051"> <h4 class="title">Non‐steroidal anti‐inflammatory drugs (NSAIDs)</h4> <section id="CD007373-sec-0052"> <h5 class="title">Pain: at tenaculum placement, during IUC insertion, and after (up to 6 hours)</h5> <p>Seven trials examined non‐steroidal anti‐inflammatory drugs (NSAIDs): two of oral naproxen, four of oral ibuprofen, and one of ketorolac injected. All assessed pain during IUC insertion. Two recent trials also assessed pain at tenaculum placement. Three studies of varying age examined pain after IUC insertion. </p> <section id="CD007373-sec-0053"> <h6 class="title">Naproxen</h6> <p>Two trials compared different doses of naproxen versus placebo. <a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> examined naproxen 300 mg, while <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> used naproxen 550 mg. For <a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>, the medication was taken the night before and 90 minutes prior to IUC insertion. Both groups received a lidocaine paracervical block prior to IUD insertion. Two more doses of naproxen were scheduled for two and six hours after IUC insertion. Of 50 participants, 48 were nulliparous. The study groups did not differ significantly in mean pain score during or immediately after IUD insertion (<a href="./references#CD007373-fig-0004" title="">Analysis 1.1</a>). However, the naproxen group had lower mean pain scores than the placebo group at one and two hours after IUC insertion: mean difference (MD) ‐1.04 (95% CI ‐1.67 to ‐0.41; participants = 50) and MD ‐0.98 (95% CI ‐1.64 to ‐0.32; participants = 41), respectively (<a href="./references#CD007373-fig-0005" title="">Analysis 1.2</a>). Group means did not differ significantly at later time points (<a href="./references#CD007373-fig-0005" title="">Analysis 1.2</a>). Women could request additional pain medication, but were then considered to be dropouts. The investigators analyzed length of time in study without needing additional analgesia. Within the 24‐hour study period, 7 of 24 participants assigned to naproxen asked for additional medication compared with 17 of 26 in the placebo group (reported P = 0.01). <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> administered 550 mg of naproxen one hour before IUD insertion. Participants were multiparous. The naproxen group had a lower mean for pain during IUD insertion compared with the placebo group (MD ‐1.94, 95% CI ‐2.35 to ‐1.53; participants = 68) (<a href="./references#CD007373-fig-0006" title="">Analysis 2.1</a>). This trial also studied tramadol; those results are shown in 'Other interventions' below. </p> </section> <section id="CD007373-sec-0054"> <h6 class="title">Ibuprofen</h6> <p>Four trials examined ibuprofen (400 mg to 800 mg) versus placebo. Administration of 400 mg ibuprofen at least 45 minutes prior to IUD insertion had no effect on pain during IUD insertion (<a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a>). Pain scores were not normally distributed. Median pain scores during IUD insertion were 1.0 for both the ibuprofen and control arms, using a 10 cm VAS (<a href="./references#CD007373-fig-0008" title="">Analysis 3.1</a>; participants = 2018). Increasing age, lower parity, longer time since last pregnancy, and no lactation were associated with increased pain, but ibuprofen was no more effective in any of those groups. Similarly, 600 mg of ibuprofen administered one to four hours prior to insertion did not show an effect on pain (<a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a>). The median pain scores for the ibuprofen and placebo groups at IUD insertion were 3.3 and 2.5 (<a href="./references#CD007373-fig-0009" title="">Analysis 4.1</a>; participants = 55). Of 27 women in the ibuprofen arm, 18 reported moderate to severe pain (3 or greater) compared with 14 women of 28 in the placebo arm (<a href="./references#CD007373-fig-0010" title="">Analysis 4.2</a>). Median pain scores after four to six hours did not differ significantly (<a href="./references#CD007373-fig-0009" title="">Analysis 4.1</a>). Women were allowed to take additional pain medication after IUD insertion if needed. Three women in the ibuprofen group and four in the placebo group did so, and the investigators excluded them from further analysis of pain data. </p> <p>The other two ibuprofen trials compared ibuprofen 800 mg versus placebo, administered 30 to 45 minutes prior to the procedure (<a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a>; <a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a>). The study arms did not differ significantly in mean scores for pain with tenaculum placement or during IUD insertion (<a href="./references#CD007373-fig-0011" title="">Analysis 5.1</a>; <a href="./references#CD007373-fig-0012" title="">Analysis 5.2</a>; participants = 81) (<a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a>). Median scores for pain during IUD insertion reportedly did not differ significantly between the groups overall nor when the analysis was stratified by parity (<a href="./references#CD007373-fig-0013" title="">Analysis 5.3</a>; participants = 202) (<a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a>). </p> </section> <section id="CD007373-sec-0055"> <h6 class="title">Ketorolac</h6> <p>For <a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a>, results came from a conference abstract. Ketorolac 30 mg was injected intramuscularly, 30 minutes before IUD insertion. The placebo was saline injection. The ketorolac group had a lower median pain score than the placebo group at five minutes after IUD insertion (1.1 versus 2.5; reported P = 0.003; participants = 67) (<a href="./references#CD007373-fig-0014" title="">Analysis 6.1</a>) and at 15 minutes after IUD insertion (0.6 versus 2.5; reported P &lt; 0.001) (<a href="./references#CD007373-fig-0014" title="">Analysis 6.1</a>). The study arms did not differ significantly in mean scores during tenaculum placement or during IUD insertion (data not provided). Within the nulliparous subgroup, women treated with ketorolac had a lower median score for pain at IUD insertion (5.8 versus 8.2; reported P = 0.016) (<a href="./references#CD007373-fig-0014" title="">Analysis 6.1</a>). </p> </section> </section> <section id="CD007373-sec-0056"> <h5 class="title">Side effects or adverse events</h5> <p>Three NSAID trials had information on side effects. Two stated no adverse events occurred (<a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a>; <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) with ibuprofen and naproxen respectively. In <a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>, participants recorded a list of symptoms several times during the study of naproxen with lidocaine paracervical block. The report abstract noted no "untoward effects" occurred. </p> </section> <section id="CD007373-sec-0057"> <h5 class="title">Satisfaction</h5> <p>One NSAID trial with multiparous women had satisfaction data. For <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>, women in the naproxen group were less likely to report the insertion as 'unpleasant' compared with those in the placebo group (OR 0.02, 95% CI 0.01 to 0.09; participants = 68) (<a href="./references#CD007373-fig-0007" title="">Analysis 2.2</a>). The women who received naproxen were also less likely to "not prefer" the medication for future IUD insertion (OR 0.02, 95% CI 0.00 to 0.08; participants = 68) (<a href="./references#CD007373-fig-0007" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD007373-sec-0058"> <h4 class="title">Lidocaine</h4> <section id="CD007373-sec-0059"> <h5 class="title">Pain: at tenaculum placement, during IUC insertion, and after (up to 6 hours)</h5> <p>Of 12 trials, 8 assessed pain at tenaculum placement and 11 measured pain during IUC insertion. Five reported on pain after IUC insertion, from five minutes to six hours post‐procedure. </p> <section id="CD007373-sec-0060"> <h6 class="title">2% gel versus placebo (topical)</h6> <p>Five trials compared a 2% gel versus placebo; one also included a group with no intervention. We combined three studies in meta‐analysis (<a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a>; <a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a>; <a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a>). <a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> and <a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> applied the gel with a swab, one minute before tenaculum placement or sounding the uterus respectively. Three minutes before tenaculum placement, <a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> used a syringe to apply 3 mL of gel and insert another 3 mL. In meta‐analysis with two of the trials, mean pain at tenaculum placement did not differ significantly between the groups (<a href="./references#CD007373-fig-0015" title="">Analysis 7.1</a>; participants = 345). Pain during IUD insertion did not differ significantly in meta‐analysis of the three trials (<a href="./references#CD007373-fig-0016" title="">Analysis 7.2</a>; participants = 409). Other analyses within individual trials showed that the study arms did not differ significantly, including mean pain scores at 20 minutes after IUD insertion (<a href="./references#CD007373-fig-0017" title="">Analysis 8.1</a>; participants = 145) (<a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a>). When the analysis was stratified by parity in <a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a>, mean scores for pain during IUD insertion did not differ significantly by study arm (reported P = 0.87 for nulliparous; reported P = 0.39 for parous; participants = 200). One trial also compared the 2% gel with no intervention; the study arms did not differ significantly for pain scores during IUD insertion (<a href="./references#CD007373-fig-0020" title="">Analysis 9.1</a>; participants = 63) (<a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a>). </p> <p>Two trials reported median pain scores (<a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a>; <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>). <a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> applied 0.5 to 1 mL of gel topically and inserted 2 to 3 mL with an angiocatheter, three minutes before starting the IUD insertion. Pain scores were not normally distributed. The study groups did not differ significantly in median pain scores at tenaculum placement or during IUD insertion (<a href="./references#CD007373-fig-0021" title="">Analysis 10.1</a>; participants = 200). When stratified by parity, the study arms did not differ significantly either (<a href="./references#CD007373-fig-0022" title="">Analysis 10.2</a>). In <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>, participants self administered 5 mL of gel vaginally at least five minutes prior to IUD insertion. Results were in a conference abstract. Participants were nulliparous. The median difference in pain between baseline and tenaculum placement was lower for the lidocaine group compared with the placebo group (32 versus 56; reported P = 0.030; participants = 64) (<a href="./references#CD007373-fig-0023" title="">Analysis 10.3</a>). For median difference in pain between baseline and IUD insertion, the groups were not significantly different (<a href="./references#CD007373-fig-0023" title="">Analysis 10.3</a>). </p> </section> <section id="CD007373-sec-0061"> <h6 class="title">Other lidocaine formulations versus placebo (topical or infused)</h6> <p>Four trials used other lidocaine formulations or application methods. Two studies examined a novel cream or gel versus placebo (<a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a>; <a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>). <a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> used a short‐acting 4% lidocaine gel. Participants were nulliparous. Using an applicator at five minutes before IUC insertion, the investigators applied 8 mL total (on surface of portio, in cervical canal, and into uterine cavity). Compared with the placebo group, the lidocaine group had lower mean scores for pain with IUC insertion as assessed within 10 minutes (MD ‐15.90, 95% CI ‐22.77 to ‐9.03; participants = 209) (<a href="./references#CD007373-fig-0024" title="">Analysis 11.1</a>) and for pain at 30 minutes post‐insertion (MD ‐11.10, 95% CI ‐19.05 to ‐3.15; participants = 114) (<a href="./references#CD007373-fig-0025" title="">Analysis 11.2</a>). Mean pain scores did not differ significantly at one hour post‐procedure (<a href="./references#CD007373-fig-0026" title="">Analysis 11.3</a>; participants = 208). Women in the lidocaine group were less likely than those in the placebo group to receive additional analgesic while in the clinic (OR 0.42, 95% CI 0.21 to 0.80; participants = 218) (<a href="./references#CD007373-fig-0027" title="">Analysis 11.4</a>). <a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> examined EMLA cream, consisting of 2.5% lidocaine and 2.5% prilocaine. Investigators applied 5 grams on the cervix and cervical opening, seven minutes before IUD insertion. The EMLA group had a lower mean pain score for tenaculum use compared with the placebo group (MD ‐2.78, 95% CI ‐3.66 to ‐1.90; participants = 92) (<a href="./references#CD007373-fig-0029" title="">Analysis 12.1</a>). Mean pain score related to IUC insertion was assessed after removing the insertion tube. The EMLA group had a lower pain score than the placebo group (MD ‐1.96, 95% CI ‐3.00 to ‐0.92; participants = 92) (<a href="./references#CD007373-fig-0030" title="">Analysis 12.2</a>). </p> <p>Two trials compared a different application method, i.e., infusion or spray, versus saline as placebo (<a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a>; <a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a>). <a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> examined intrauterine infusion of 2% lidocaine. Three minutes before IUD insertion, the investigator infused 1.2 mL into the endometrial cavity (lower third, middle, and top of cavity). The study arms did not differ significantly in mean pain scores at tenaculum placement (<a href="./references#CD007373-fig-0031" title="">Analysis 13.1</a>), with IUD insertion (<a href="./references#CD007373-fig-0032" title="">Analysis 13.2</a>), or for "global score" at end of visit (<a href="./references#CD007373-fig-0033" title="">Analysis 13.3</a>) (participants = 40 for each analysis). In <a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a>, 11 women took NSAIDs prior to enrollment, but pain scores did not differ by NSAID use (<a href="./references#CD007373-fig-0034" title="">Analysis 13.4</a>). <a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> used a 10% lidocaine spray; the participants were parous. Three minutes before tenaculum placement, investigators administered three puffs to the cervical surface and one puff towards the cervical os for a total of 40 mg. Median score for pain during IUD insertion was lower for the lidocaine group than for the placebo group (1.00 versus 3.00; reported P &lt; 0.001; participants = 200) (<a href="./references#CD007373-fig-0035" title="">Analysis 14.1</a>). </p> </section> <section id="CD007373-sec-0062"> <h6 class="title">1% paracervical or 2% intracervical block</h6> <p>Three trials injected lidocaine; the comparisons were no intervention, placebo, or oral ibuprofen. Two trials compared a paracervical block of 1% lidocaine (10 mL) to no intervention (control) (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>; <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>) or to saline as placebo (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>). The intervention occurred three minutes before starting the IUC insertion (<a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>) or five minutes before IUC insertion (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>). In <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>, the lidocaine group had a lower median pain score at tenaculum placement compared with the no‐intervention group (12 versus 28; reported P = 0.008; participants = 50) (<a href="./references#CD007373-fig-0036" title="">Analysis 15.1</a>). The study arms did not differ significantly for pain with IUD insertion or at five minutes after the procedure (<a href="./references#CD007373-fig-0036" title="">Analysis 15.1</a>). In <a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>, median pain scores were lower with lidocaine compared with saline placebo or no intervention at tenaculum placement (4 versus 7), at IUD insertion (2 versus 6), and at five minutes post‐procedure (1 versus 4) (reported P &lt; 0.01; participants = 95) (<a href="./references#CD007373-fig-0036" title="">Analysis 15.1</a>). </p> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> compared an intracervical block of 2% lidocaine (1.8 mL), five minutes before LNG‐IUS insertion, versus oral ibuprofen 400 mg at one hour prior to LNG‐IUS insertion. Participants were nulliparous or without a previous vaginal delivery. For pain immediately after IUS insertion, the investigators analyzed the VAS scores as mild (0 to 30 mm), moderate (40 to 60 mm), or severe (70 to 100 mm). Presumably these categories were only for pain immediately after IUS insertion, as means were not shown for that time point but were available for all others. The study arms did not differ significantly in mean pain assessed at two and six hours after IUS insertion (participants = 98; <a href="./references#CD007373-fig-0039" title="">Analysis 16.1</a>). The investigators also grouped the VAS scores as mild, moderate, or severe pain. The proportions reporting moderate or severe pain did not differ significantly (<a href="./references#CD007373-fig-0040" title="">Analysis 16.2</a>). </p> </section> </section> <section id="CD007373-sec-0063"> <h5 class="title">Side effects or adverse events</h5> <p>Six trials, four of which studied lidocaine gel formulations, provided varying information on side effects or adverse events. In a trial of 2% lidocaine gel, <a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> assessed nausea and dizziness with four‐point scales. The study arms did not differ significantly in the proportions with moderate or severe nausea or who were moderately or severely dizzy (participants = 145; <a href="./references#CD007373-fig-0018" title="">Analysis 8.2</a>). Complications were one vasovagal reaction and one IUD inadvertently pulled out with scissors and replaced (groups not specified). Two other studies of 2% lidocaine gel provided limited information. In <a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a>, adverse events were reported over six months and included five expulsions (one for lidocaine and four for placebo), as well as one perforation and one case of pelvic inflammatory disease (groups not specified). <a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> stated the groups were "highly similar" for side effects, e.g., nausea, vomiting, and dizziness. In <a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>, the proportions of women with at least one adverse event did not differ significantly between the 4% lidocaine group and the placebo group (participants = 218; <a href="./references#CD007373-fig-0028" title="">Analysis 11.5</a>). </p> <p>Two studies of lidocaine paracervical block reported on side effects. In <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>, vasovagal symptoms and bleeding did not differ significantly between the group with paracervical block and the group with no intervention (participants = 50; <a href="./references#CD007373-fig-0037" title="">Analysis 15.2</a>). No vasovagal syncope occurred, nor any uterine perforation. The study groups in <a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a> did not differ significantly for complications (paracervical block of lidocaine or of saline or no intervention). Vasovagal syncope occurred in five participants (reported P = 0.36; participants = 95) (<a href="./references#CD007373-fig-0038" title="">Analysis 15.3</a>). The groups were similar for vasovagal symptoms, e.g., nausea and vomiting (reported P = 0.06). No bleeding or uterine perforation occurred. </p> </section> <section id="CD007373-sec-0064"> <h5 class="title">Satisfaction or acceptability</h5> <p>Of four trials of lidocaine 2% that assessed satisfaction or acceptability, two had comparative data. <a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> assessed acceptability with a five‐point scale. The lidocaine gel group did not differ significantly from the placebo group in the proportion finding the pain during IUD insertion to be mostly or completely acceptable (participants = 143; <a href="./references#CD007373-fig-0019" title="">Analysis 8.3</a>). In <a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a>, the group with lidocaine injected did not differ significantly from the ibuprofen group in the proportion rating the experience as uncomfortable or very uncomfortable (participants = 98; <a href="./references#CD007373-fig-0041" title="">Analysis 16.3</a>). Two trials provided percentages for satisfaction overall rather than by study arm (<a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a>; <a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a>). </p> </section> </section> <section id="CD007373-sec-0065"> <h4 class="title">Misoprostol</h4> <section id="CD007373-sec-0066"> <h5 class="title">Pain: at tenaculum placement, during IUC insertion, and after (up to 6 hours)</h5> <p>All 10 trials assessed pain during IUC insertion. One measured pain at tenaculum placement. Four assessed pain after IUC insertion, ranging from five minutes to before clinic departure. </p> <section id="CD007373-sec-0067"> <h6 class="title">Misoprostol plus diclofenac versus diclofenac</h6> <p>Two trials compared misoprostol 400 µg sublingually plus diclofenac versus diclofenac alone at one hour before IUC insertion (<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>; <a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>). Median pain scores for the misoprostol and control groups at the time of insertion did not differ significantly in either study (255 and 59 participants respectively; <a href="./references#CD007373-fig-0042" title="">Analysis 17.1</a>). Further, the misoprostol groups in these trials had the same median and range as did the placebo groups. Participants in <a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> were nulliparous. </p> </section> <section id="CD007373-sec-0068"> <h6 class="title">Misoprostol versus placebo</h6> <p>Eight trials compared misoprostol 400 µg versus placebo. Participants were instructed to administer the medication via a specific route and at a specific time prior to IUC insertion: vaginally at three hours (<a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a>) or four hours (<a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>); sublingually at three hours (<a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a>); buccally at 90 minutes (<a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a>), two to four hours (<a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>), two to eight hours (<a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>); or either buccally or vaginally at three to four hours (<a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>) or at two hours (<a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a>). </p> <p>We combined four trials in a meta‐analysis (<a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a>; <a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a>; <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a>; <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>). The misoprostol group had a higher mean score for pain during IUD insertion (standardized mean difference (SMD) 0.27, 95% CI 0.07 to 0.46; participants = 400) (<a href="./references#CD007373-fig-0046" title="">Analysis 18.2</a>). When the analysis was stratified by parity in <a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a>, mean scores for pain during IUD insertion did not differ significantly by study arm (participants = 199; <a href="./references#CD007373-fig-0047" title="">Analysis 18.3</a>). Participants in <a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> and <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> were nulliparous. In <a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a>, the study arms did not differ significantly for pain with tenaculum placement (participants = 35; <a href="./references#CD007373-fig-0045" title="">Analysis 18.1</a>) or pain five minutes after IUD insertion (<a href="./references#CD007373-fig-0048" title="">Analysis 18.4</a>). In <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>, mean score for highest pain before discharge was higher for the misoprostol group (MD 7.60, 95% CI 6.48 to 8.72; participants = 105) (<a href="./references#CD007373-fig-0048" title="">Analysis 18.4</a>). The women had no pregnancy of 14 weeks or longer. </p> <p>The other four trials of misoprostol 400 µg versus placebo had varied outcome measures and analyses (<a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>; <a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a>; <a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>; <a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>). Participants were nulliparous in <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> and <a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>. In <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>, the groups did not differ significantly for mean score for "highest pain level," assessed immediately after IUD insertion (after instrument removal) or mean pain score before discharge from clinic (participants = 82; <a href="./references#CD007373-fig-0048" title="">Analysis 18.4</a>). After IUC insertion, most women in <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> took additional pain medication: 68% of misoprostol group; 65% of placebo group). Of the misoprostol group, 8% took NSAIDs prior to IUC insertion, as did 5% of the placebo group. In <a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>, the misoprostol group had a higher median score for pain immediately after IUD insertion (46 versus 34; reported P = 0.044) and prior to discharge from clinic (35.5 versus 20.5; reported P = 0.024) (participants = 73; <a href="./references#CD007373-fig-0049" title="">Analysis 18.5</a>). The women had no pregnancy of 20 weeks or longer. Two trials reported pain scores as categorical variables. <a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> apparently used four categories. Participants had the IUC removed and then the LNG‐IUS inserted. The groups did not differ significantly in pain assessments (participants = 89; <a href="./references#CD007373-fig-0050" title="">Analysis 18.6</a>). <a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> used a scale of 0 to 10, but analyzed pain dichotomously as absent or mild (0 to 5) versus moderate or severe (6 to 10). Women in the misoprostol group were less likely to have moderate or severe pain compared with those in the placebo group (OR 0.30, 95% CI 0.16 to 0.55; participants = 179) (<a href="./references#CD007373-fig-0051" title="">Analysis 18.7</a>). </p> </section> </section> <section id="CD007373-sec-0069"> <h5 class="title">Side effects or adverse events</h5> <section id="CD007373-sec-0070"> <h6 class="title">Misoprostol plus diclofenac versus diclofenac</h6> <p>The two studies of misoprostol plus diclofenac reported side effects. In <a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>, the study groups did not differ significantly for "any side effect," which included shivering, diarrhea, nausea, and vomiting (<a href="./references#CD007373-fig-0043" title="">Analysis 17.2</a>). The only side effect that differed significantly between the two groups was shivering (OR 5.48, 95% CI 1.41 to 21.33; participants = 79) (<a href="./references#CD007373-fig-0043" title="">Analysis 17.2</a>). Side effects were measured after IUD insertion. For <a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>, women in the misoprostol group were more likely than those in the control group to report having had a headache (OR 5.68, 95% CI 1.23 to 26.19; participants = 255) or abdominal pain (OR 3.93, 95% CI 1.41 to 10.97; participants = 230) (<a href="./references#CD007373-fig-0043" title="">Analysis 17.2</a>). While the misoprostol group was also more likely to have nausea in <a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>, the meta‐analysis with <a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> did not show a significant difference (participants = 308; <a href="./references#CD007373-fig-0043" title="">Analysis 17.2</a>). </p> </section> <section id="CD007373-sec-0071"> <h6 class="title">Misoprostol versus placebo</h6> <p>Of eight trials with this comparison, six provided data on side effects. A meta‐analysis of four trials showed women in the misoprostol group were more likely to report abdominal cramping than those in the placebo group (OR 2.64, 95% CI 1.46 to 4.76; participants = 466) (<a href="./references#CD007373-fig-0052" title="">Analysis 18.8</a>). None of the other side effects differed significantly between the groups, including results of various meta‐analyses (<a href="./references#CD007373-fig-0052" title="">Analysis 18.8</a>). Two trials did not have data on side effects or complications. <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> assessed side effects one week after IUD insertion but did not provide results. <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> did not gather data on specific side effects. </p> </section> </section> <section id="CD007373-sec-0072"> <h5 class="title">Satisfaction</h5> <section id="CD007373-sec-0073"> <h6 class="title">Misoprostol plus diclofenac versus diclofenac</h6> <p>For these two studies, the study arms did not differ significantly for being "satisfied" with the insertion experience (participants = 255; <a href="./references#CD007373-fig-0044" title="">Analysis 17.3</a>) (<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) or for rating the insertion experience as "very little unpleasant" (participants = 79; <a href="./references#CD007373-fig-0044" title="">Analysis 17.3</a>) (<a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>). However, in <a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>, the group with misoprostol plus diclofenac was less likely than the diclofenac‐only group to choose the treatment again (OR 0.30, 95% CI 0.14 to 0.65; participants = 255) or to recommend it to a friend (OR 0.36, 95% CI 0.16 to 0.81; participants = 255) (<a href="./references#CD007373-fig-0044" title="">Analysis 17.3</a>). </p> </section> <section id="CD007373-sec-0074"> <h6 class="title">Misoprostol versus placebo</h6> <p>Five of these eight trials had data on satisfaction. Women in the misoprostol group were more likely to rate the IUD insertion experience as slightly disagreeable or not disagreeable in <a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> (OR 4.34, 95% CI 2.32 to 8.12; participants = 179) (<a href="./references#CD007373-fig-0053" title="">Analysis 18.9</a>). At one week after IUC insertion, the study groups did not differ significantly for satisfaction in <a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> (participants = 73; <a href="./references#CD007373-fig-0053" title="">Analysis 18.9</a>) nor for likelihood of having another IUD inserted in <a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> (participants = 102; <a href="./references#CD007373-fig-0053" title="">Analysis 18.9</a>). The study arms also did not differ in the likelihood of recommending IUD insertion to a friend in meta‐analysis (participants = 167; <a href="./references#CD007373-fig-0053" title="">Analysis 18.9</a>). </p> <p>The remaining two trials assessed satisfaction one to two weeks after IUC insertion (<a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a>; <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a>). The reports had percentages for each study arm and P values but no actual counts (<a href="./references#CD007373-fig-0054" title="">Analysis 18.10</a>). Reportedly, the study arms did not differ significantly for satisfaction in either study, for pain not influencing future IUD use in <a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> (participants = 83), and for definitely recommending IUD use to a friend in <a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> (participants = 61). </p> </section> </section> </section> <section id="CD007373-sec-0075"> <h4 class="title">Other interventions</h4> <section id="CD007373-sec-0076"> <h5 class="title">Pain: at tenaculum placement, during IUC insertion, and after (up to six hours)</h5> <p>These five trials assessed pain during IUC insertion. However, only the studies of nitric oxide donors reported on pain at tenaculum placement and pain after IUC insertion (30 minutes post‐procedure). </p> <p>Two pilot studies examined nitric oxide donors versus placebo among nulliparous women. The experimental interventions were nitroprusside 10 mg as 1% aqueous gel administered immediately prior to IUC insertion (<a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>) and 1 mL of 0.5 mg nitroglycerin ointment at 30 to 45 minutes before the procedure (<a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a>). <a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> showed no significant difference between the groups in pain scores at tenaculum placement (participants = 23; <a href="./references#CD007373-fig-0055" title="">Analysis 19.1</a>). Meta‐analysis of these two small trials showed no effect of the intervention on pain during IUD insertion (participants = 47; <a href="./references#CD007373-fig-0056" title="">Analysis 19.2</a>). In other analyses, the groups did not differ significantly in <a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> for pain 30 minutes after IUD insertion (<a href="./references#CD007373-fig-0057" title="">Analysis 19.3</a>). <a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> also reported no significant difference in pain at those time points; results were shown in a figure without actual values. </p> <p>Among multiparous women, <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> compared tramadol 50 mg versus naproxen 500 mg, administered one hour before IUD insertion. Results for naproxen versus placebo are shown in the section on NSAIDs. The tramadol group had a lower mean score than the naproxen group for pain during IUD insertion (MD ‐0.63, 95% CI ‐0.94 to ‐0.32; participants = 69) (<a href="./references#CD007373-fig-0059" title="">Analysis 20.1</a>). </p> <p>Two trials had non‐pharmacological interventions. <a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> used lavender oil, three drops on cotton, inhaled 30 minutes before and during the procedure. Women in the lavender group were no more likely than those in the placebo group to have medium or severe pain scores after the intervention (participants = 106; <a href="./references#CD007373-fig-0061" title="">Analysis 21.1</a>). Median pain scores and interquartile ranges were the same for both study groups (<a href="./references#CD007373-fig-0062" title="">Analysis 21.2</a>). In <a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a>, the participants consumed one liter of water an hour before the appointment. The investigators examined the effect of bladder emptying before IUD insertion (immediate) versus after IUD insertion (delayed). The study arms did not show a difference in pain during IUD insertion (participants = 196; <a href="./references#CD007373-fig-0063" title="">Analysis 22.1</a>). </p> </section> <section id="CD007373-sec-0077"> <h5 class="title">Side effects or adverse events</h5> <p>Four trials reported on side effects. The two studies of nitric oxide donors reported no significant difference between the study groups in side effects at any time point (<a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>; <a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a>). Both provided a list of potential side effects assessed. In <a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>, the nitroprusside group had two participants with vasovagal reactions while the placebo group had none. <a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> had no vasovagal reactions or other complications in the trial of nitroglycerin ointment. </p> <p>The other two trials reported not having any side effects. These were the studies of lavender essence (<a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a>) and of tramadol versus naproxen versus placebo (<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>). </p> </section> <section id="CD007373-sec-0078"> <h5 class="title">Satisfaction or acceptability</h5> <p>Three trials had data in this area. In meta‐analysis, the two pilot trials of nitric oxide donors showed no significant difference in mean scores for satisfaction with pain control or satisfaction with the procedure (participants = 48; <a href="./references#CD007373-fig-0058" title="">Analysis 19.4</a>). However, in <a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a>, the nitroprusside group appeared to have a lower mean score for satisfaction with the procedure. In <a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>, the tramadol and naproxen groups did not differ significantly in rating the experience as unpleasant or in not preferring the medication for future IUD insertion (participants = 69; <a href="./references#CD007373-fig-0060" title="">Analysis 20.2</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007373-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007373-sec-0079"></div> <section id="CD007373-sec-0080"> <h3 class="title" id="CD007373-sec-0080">Summary of main results</h3> <p>This section emphasizes our sensitivity analysis or examination of trials with sufficient outcome data and evidence of moderate or high quality. We focus on meta‐analyses as well as significant differences within individual trials. Pain results for each study are summarized in <a href="#CD007373-tbl-0007">Table 2</a>. Results for side effects and for satisfaction are summarized in <a href="#CD007373-tbl-0008">Table 3</a>. The tables identify results excluded from this synthesis. </p> <section id="CD007373-sec-0081"> <h4 class="title">Lidocaine formulations</h4> <p> <ul id="CD007373-list-0001"> <li> <p>Meta‐analysis of three trials showed that 2% gel had no effect on pain during IUC insertion (<a href="./full#CD007373-tbl-0001">summary of findings Table for the main comparison</a>). Pain at tenaculum placement did not differ between the study arms in meta‐analysis of two trials. </p> </li> </ul> <ul id="CD007373-list-0002"> <li> <p>Four other studies indicated some effect of the lidocaine on pain (<a href="./full#CD007373-tbl-0002">summary of findings Table 2</a>). </p> <ul id="CD007373-list-0003"> <li> <p>One trial applied a lidocaine and prilocaine cream on the cervix and cervical opening. The experimental group had a lower mean score for pain with IUC insertion compared with the placebo group. </p> </li> <li> <p>A study with nulliparous women applied a short‐acting 4% lidocaine formulation on the surface of the portio, in the cervical canal, and into the uterine cavity. The lidocaine group had a lower mean pain score than the placebo group at 10 and 30 minutes after IUC insertion. </p> </li> <li> <p>A trial with parous women sprayed 10% lidocaine on the cervical surface and toward the cervical os. The lidocaine group had a lower median pain score for IUC insertion compared with the placebo group. </p> </li> <li> <p>The remaining trial used a 1% paracervical block, and reported a lower median pain score at tenaculum placement for the lidocaine group versus a group with no intervention. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD007373-sec-0082"> <h4 class="title">NSAID or tramadol</h4> <p> <ul id="CD007373-list-0004"> <li> <p>Of the NSAID trials, two had some significant differences in pain scores between the groups; one also examined tramadol (<a href="./full#CD007373-tbl-0003">summary of findings Table 3</a>). For pain during IUC insertion among multiparous women, a group with tramadol 50 mg had a lower mean score compared with a group that received naproxen 550 mg. Further, the naproxen group had a lower mean score than a placebo group. In another study, multiple doses of naproxen 300 mg led to lower pain scores at one and two hours after IUC insertion. Nearly all the women were nulliparous in that small study. </p> </li> </ul> <ul id="CD007373-list-0005"> <li> <p>For satisfaction, the naproxen 550 mg group was more likely than the placebo group to be satisfied with the experience (<a href="./full#CD007373-tbl-0003">summary of findings Table 3</a>). Specifically, the naproxen group was less likely to report the insertion experience as "unpleasant," and less likely to "not prefer" the treatment for future IUC insertion. The women were multiparous, </p> </li> </ul> </p> </section> <section id="CD007373-sec-0083"> <h4 class="title">Misoprostol 400 mg</h4> <p> <ul id="CD007373-list-0006"> <li> <p>Four trials were included in meta‐analysis. The misoprostol group had a higher mean pain score with IUC insertion compared with the placebo group (<a href="./full#CD007373-tbl-0004">summary of findings Table 4</a>). </p> </li> </ul> <ul id="CD007373-list-0007"> <li> <p>Three individual studies showed some differences in pain between the misoprostol and placebo groups (<a href="./full#CD007373-tbl-0004">summary of findings Table 4</a>). </p> <ul id="CD007373-list-0008"> <li> <p>In one trial, the misoprostol group had a higher median score for pain at IUC insertion and for pain score before leaving the clinic. Participants had no pregnancy of 20 weeks or more. </p> </li> <li> <p>In another study, the misoprostol group had a higher mean score for pain before leaving the clinic. Participants had no pregnancy of 14 weeks or more. </p> </li> <li> <p>A trial with nulliparous women showed fewer in the misoprostol group reported moderate or severe pain at IUC insertion than those in the placebo group. </p> </li> </ul> </li> </ul> <ul id="CD007373-list-0009"> <li> <p>The misoprostol trials assessed side effects and some examined satisfaction (<a href="./full#CD007373-tbl-0004">summary of findings Table 4</a>). </p> <ul id="CD007373-list-0010"> <li> <p>In meta‐analysis of four trials, cramping was more likely in the misoprostol group than the placebo group. </p> </li> <li> <p>Regarding satisfaction, the trial with nulliparous women mentioned above showed the misoprostol group was more likely than the placebo group to rate the experience more favorably, i.e., as not disagreeable or slightly disagreeable. </p> </li> </ul> </li> </ul> <ul id="CD007373-list-0011"> <li> <p>Two trials of misoprostol also used diclofenac with both groups (<a href="./full#CD007373-tbl-0005">summary of findings Table 5</a>). </p> <ul id="CD007373-list-0012"> <li> <p>Both studies had some side effects. The misoprostol group was more likely to report shivering in the trial with nulliparous women. In the other trial, the misoprostol group was more likely to report headache or abdominal pain; the women had prior cesarean delivery only. </p> </li> <li> <p>For satisfaction in the trial with women who had cesarean delivery only, the misoprostol group was less likely to choose the treatment again or to recommend it to a friend. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD007373-sec-0084"> <h4 class="title">Other results</h4> <p>We excluded from the sensitivity analysis two conference abstracts and one full article (<a href="#CD007373-tbl-0007">Table 2</a>). </p> <p> <ul id="CD007373-list-0013"> <li> <p>Preliminary results indicated a group that received the NSAID ketorolac had a lower pain score than the placebo group shortly after IUC insertion. </p> </li> <li> <p>A trial of 1% lidocaine paracervical block had limited reporting. However, the lidocaine group had a lower pain score at tenaculum placement, during IUC insertion, and shortly afterward. </p> </li> </ul> </p> </section> </section> <section id="CD007373-sec-0085"> <h3 class="title" id="CD007373-sec-0085">Overall completeness and applicability of evidence</h3> <p>Of the 33 included trials, 29 were published in the last five years. Nearly all used modern IUC, either levonorgestrel‐releasing or copper‐containing. Many trials allowed the participants to choose the type of IUC. No study compared insertion‐related pain with devices of smaller versus larger diameter. An early trial showing a benefit of naproxen may not be relevant (<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>). The IUD used (the Dalkon Shield) had unique insertion mechanics and is no longer available. </p> <p>The interventions covered four large categories: NSAIDs, lidocaine, misoprostol, and 'other.' Of the NSAIDs studied, naproxen and ibuprofen are commonly available but ketorolac less so. In some cases, the dose may have been lower than that sometimes used in clinical practice for acute gynecological pain. Various lidocaine formulations were examined, using varied amounts and administration methods: 2% gel; 1% and 2% formulations injected or infused; 4% gel; 10% spray; and a cream containing lidocaine and prilocaine. The misoprostol dose was standard across trials; administration was sublingual, buccal, or vaginal. The 'other' interventions included two nitric oxide donors (nitroprusside and nitroglycerine), an opioid (tramadol), a physical intervention (bladder emptying time) and an essential oil (lavender). </p> <p>Pain measurements were taken at various time points, making comparisons difficult. Assessment of pain during or immediately after a procedure may differ from assessment of the pain at some later time. For pain after insertion, measurements ranged from five minutes to several hours later. A few trials assessed 'highest' level of pain after IUC insertion and before leaving the clinic, which was not comparable to measurement at a specific time. Most reports presented mean scores, while some noted the pain scores were not normally distributed. In those cases, the investigators appropriately used a nonparametric method for analysis. We did not combine results from those trials in meta‐analysis, even if means were also reported. In addition, a few trials provided categorical analysis of pain, e.g., moderate or severe pain, and two also reported means. We did not focus on levels of pain; the choice and meaning of cut‐offs may vary across trials. </p> <p>We did not search for trials with comparative data by parity. Inclusion criteria regarding parity varied across studies (<a href="#CD007373-tbl-0006">Table 1</a>): 16 did not specify parity (one with 48 nulliparous/50 women), 10 were limited to nulliparous women, two included only parous women, and one stratified the sample by parity. Four trials had one of the following limitations: women with a prior cesarean delivery, those requesting abortion, or women having no pregnancy longer than 13 6/7 weeks or no longer than 20 6/7 weeks. A few studies analyzed the outcomes by parity; others examined overall pain scores by parity. Two ibuprofen trials found the median pain score for nulliparous women was approximately twice that for parous women (<a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a>; <a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a>). A misoprostol trial showed mean pain scores for nulliparous women that were twice those for multiparous women (<a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a>). Median pain scores did not differ much by parity in a lidocaine trial (<a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a>). A cohort study of pain with IUD insertion compared women with and without previous vaginal delivery (<a href="./references#CD007373-bbs2-0051" title="AllenRH , CareyMS , RakerC , GoyalV , MattesonK . A prospective cohort study of pain with intrauterine device insertion among women with and without vaginal deliveries. Journal of Obstetrics and Gynaecology2014;34(3):263‐7. ">Allen 2014</a>). Pain scores were lower for women with versus without vaginal delivery. Pain was also higher among women with cesarean delivery who had experienced labor and some cervical dilation. Multivariate analysis indicated that expected pain and baseline anxiety were among the significant predictors of pain scores. </p> </section> <section id="CD007373-sec-0086"> <h3 class="title" id="CD007373-sec-0086">Quality of the evidence</h3> <p>Overall, the quality of evidence was high from the individual trials. More than 80% of trials had low risk of bias for the identified criteria (<a href="#CD007373-fig-0002">Figure 2</a>). Loss to follow‐up was a minor issue for this review, given our primary outcomes were assessed while the participants were still in the clinical setting. A few studies did not use any blinding. Three trials had limited design information; two had conference abstracts and listings in a clinical trial register, and one was a full report (<a href="#CD007373-fig-0003">Figure 3</a>). </p> <p>However, we considered most of the effectiveness evidence to be of moderate quality. For the 'Summary of findings' tables, we downgraded one level if the evidence came from only one trial, as explained earlier (<a href="#CD007373-sec-0039">Data synthesis</a>). Further research may change the estimate if trials vary by types of participants (e.g., parous versus nulliparous women), timing or application of the intervention, or timing or assessment of the outcome. In some cases, the results were imprecise due to a wide confidence interval, or a large range when medians were used. </p> <p>Many trials were small studies without sufficient power to detect significant differences in pain scores. Most had a priori sample size calculations, but some were based on differences in pain scores larger than those found. However, smaller differences in VAS pain scores may not be clinically significant. For other trials, the primary outcomes did not include pain but rather provider's ease of insertion or successful insertion. </p> </section> <section id="CD007373-sec-0087"> <h3 class="title" id="CD007373-sec-0087">Agreements and disagreements with other studies or reviews</h3> <p>Several reviews have examined the use of misoprostol with IUD insertion for improving providers' ease of insertion or reducing pain for the women. Because misoprostol did not improve insertion ease and also led to more side effects, <a href="./references#CD007373-bbs2-0074" title="WaddingtonA , ReidR . More harm than good: the lack of evidence for administering misoprostol prior to IUD insertion. Journal of Obstetrics and Gynaecology Canada2012;34(12):1177‐9. ">Waddington 2012</a> recommended ceasing use of misoprostol for IUD insertion. From a systematic review of pain management for IUC insertion, <a href="./references#CD007373-bbs2-0056" title="Gemzell‐DanielssonK , MansourD , FialaC , KaunitzAM , BahamondesL . Management of pain associated with the insertion of intrauterine contraceptives. Human Reproduction Update2013;19(4):419‐27. ">Gemzell‐Danielsson 2013</a> concluded that no evidence supported the use of misoprostol 400 µg for reducing pain. They also noted the likelihood of harm due to misoprostol. <a href="./references#CD007373-bbs2-0068" title="PergialiotisV , VlachosDG , ProtopappasA , VlachosGD . Analgesic options for placement of an intrauterine contraceptive: a meta‐analysis. European Journal of Contraception and Reproductive Health Care2014;19(3):149‐60. ">Pergialiotis 2014</a> reviewed RCTs and controlled trials of analgesia for pain reduction with IUC insertion. They concluded that misoprostol led to higher pain scores and more side effects. Several trials in our review are part of a prospective meta‐analysis using individual patient data (<a href="./references#CD007373-bbs2-0072" title="TurokDK , EspeyE , EdelmanAB , LotkePS , LathropEH , TealSB , et al. The methodology for developing a prospective meta‐analysis in the family planning community. Trials2011;12:104. ">Turok 2011</a>). The trials examine use of misoprostol for providers' ease of insertion and for pain as reported by the women. That work may provide further evidence of whether misoprostol is helpful or harmful at specific time points or within certain subgroups of women. </p> <p>Some reviews addressed analgesics for reducing pain with IUC insertion. A systematic review examined RCTs that used intrauterine local anesthesia for pain with a range of gynecologic procedures, including IUC insertion (<a href="./references#CD007373-bbs2-0065" title="MercierRJ , ZerdenML . Intrauterine anesthesia for gynecologic procedures: a systematic review. Obstetrics and Gynecology2012;120(3):669‐77. ">Mercier 2012</a>). That review included one trial of IUD insertion, which was not eligible for our review (<a href="./references#CD007373-bbs2-0040" title="OlotoEJ , BromhamDR , MurtyJA . Pain and discomfort perception at IUD insertion‐‐effect of short‐duration, low‐volume, intracervical application of two percent lignocaine gel (Instillagel™)‐‐a preliminary study. British Journal of Family Planning1997;22(4):177‐80. ">Oloto 1997</a>). Women were randomized by birth date to a lignocaine 2% gel (lidocaine), a gel without the lignocaine, or usual insertion procedures. Women with the active gel had lower pain scores compared with women in the other two groups. In <a href="./references#CD007373-bbs2-0056" title="Gemzell‐DanielssonK , MansourD , FialaC , KaunitzAM , BahamondesL . Management of pain associated with the insertion of intrauterine contraceptives. Human Reproduction Update2013;19(4):419‐27. ">Gemzell‐Danielsson 2013</a>, the RCTs of pre‐insertion interventions for pain control were all included in our review. The researchers did not find any evidence to support use of pre‐insertion ibuprofen. As we noted, they stated that naproxen and the opioid tramadol may be beneficial but also that larger studies were needed. No local anesthesia appeared to be helpful. However, because of variable needs and reactions, they believed injectable local anesthesia should be available and used as the situation warranted. <a href="./references#CD007373-bbs2-0068" title="PergialiotisV , VlachosDG , ProtopappasA , VlachosGD . Analgesic options for placement of an intrauterine contraceptive: a meta‐analysis. European Journal of Contraception and Reproductive Health Care2014;19(3):149‐60. ">Pergialiotis 2014</a> included RCTs and controlled clinical trials that had single treatments and used currently available IUC. The 13 trials in their meta‐analysis were also in our review. The researchers identified paracervical lidocaine as effective for reducing pain at tenaculum placement. However, they analyzed means for those two trials that reported medians for their primary outcomes (<a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a>; <a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>), one of which stated that the data were not normally distributed. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007373-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD007373-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about risk of bias as percentages across all 33 included studies" data-id="CD007373-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about risk of bias as percentages across all 33 included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about risk of bias for each included study" data-id="CD007373-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about risk of bias for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block, Outcome 1 Mean pain scores during and immediately after IUD insertion." data-id="CD007373-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block, Outcome 1 Mean pain scores during and immediately after IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block, Outcome 2 Mean pain scores after IUD insertion." data-id="CD007373-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block, Outcome 2 Mean pain scores after IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Naproxen 550 mg versus placebo, Outcome 1 Mean pain score during IUD insertion." data-id="CD007373-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Naproxen 550 mg versus placebo, Outcome 1 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Naproxen 550 mg versus placebo, Outcome 2 Satisfaction or acceptability." data-id="CD007373-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Naproxen 550 mg versus placebo, Outcome 2 Satisfaction or acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0008"> <p> <div class="table" id="CD007373-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Ibuprofen<br/> (N = 1010)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control<br/> (N = 1008)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hubacher 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Ibuprofen 400 mg versus placebo, Outcome 1 Median pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0008">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0009"> <p> <div class="table" id="CD007373-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Ibuprofen</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jensen 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jensen 1998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After insertion, 4 to 6 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen 600 mg versus placebo, Outcome 1 Median pain scores.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0009">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Ibuprofen 600 mg versus placebo, Outcome 2 Reported moderate to severe pain during IUD insertion (3 or greater on the 1 to 10 scale)." data-id="CD007373-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Ibuprofen 600 mg versus placebo, Outcome 2 Reported moderate to severe pain during IUD insertion (3 or greater on the 1 to 10 scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Ibuprofen 800 mg versus placebo, Outcome 1 Mean pain score at tenaculum placement." data-id="CD007373-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Ibuprofen 800 mg versus placebo, Outcome 1 Mean pain score at tenaculum placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Ibuprofen 800 mg versus placebo, Outcome 2 Mean pain score at IUD insertion." data-id="CD007373-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Ibuprofen 800 mg versus placebo, Outcome 2 Mean pain score at IUD insertion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0013"> <p> <div class="table" id="CD007373-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Groups</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Ibuprofen<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38 (0 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.5 (0 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59 (0 to 97)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 (0 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Parous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 (1 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 (1 to 96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bednarek 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Ibuprofen 800 mg versus placebo, Outcome 3 Median pain score at IUD insertion.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0014"> <p> <div class="table" id="CD007373-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time point</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Ketorolac<br/> (N = 33)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (N = 34)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ngo 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 min after insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.003</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ngo 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>All women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 min after insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ngo 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.016</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Ketorolac 30 mg versus placebo, Outcome 1 Median pain scores.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0014">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lidocaine 2% versus placebo, Outcome 1 Mean pain score at tenaculum placement." data-id="CD007373-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Lidocaine 2% versus placebo, Outcome 1 Mean pain score at tenaculum placement.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Lidocaine 2% versus placebo, Outcome 2 Mean pain score during IUD insertion." data-id="CD007373-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Lidocaine 2% versus placebo, Outcome 2 Mean pain score during IUD insertion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 1 Mean pain score 20 minutes post‐insertion." data-id="CD007373-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 1 Mean pain score 20 minutes post‐insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 2 Side effects or adverse events." data-id="CD007373-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 2 Side effects or adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 3 Satisfaction or acceptability." data-id="CD007373-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Lidocaine 2% gel 6 mL versus placebo, Outcome 3 Satisfaction or acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Lidocaine 2% gel versus no intervention, Outcome 1 Mean pain score during IUD insertion." data-id="CD007373-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Lidocaine 2% gel versus no intervention, Outcome 1 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0021"> <p> <div class="table" id="CD007373-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine<br/> (N = 100)<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (N = 99)<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.16</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Lidocaine 2% gel, 2.5 to 5 mL, versus placebo, Outcome 1 Median pain scores. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0021">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0022"> <p> <div class="table" id="CD007373-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Parity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nulliparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (2 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (2 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Parous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 (0 to 9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McNicholas 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Parous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (1 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 (0 to 9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Lidocaine 2% gel, 2.5 to 5 mL, versus placebo, Outcome 2 Median pain scores by parity. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0022">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0023"> <p> <div class="table" id="CD007373-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rapkin 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.030</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rapkin 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.133</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Lidocaine 2% gel, 2.5 to 5 mL, versus placebo, Outcome 3 Median difference in pain scores from baseline. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0023">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 1 Mean pain score for IUD insertion (within 10 min of insertion." data-id="CD007373-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 1 Mean pain score for IUD insertion (within 10 min of insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 2 Mean pain score 30 min post‐insertion." data-id="CD007373-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 2 Mean pain score 30 min post‐insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 3 Mean pain score 1 h post‐insertion." data-id="CD007373-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 3 Mean pain score 1 h post‐insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 4 Additional analgesic at clinic." data-id="CD007373-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 4 Additional analgesic at clinic. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 5 Side effects or adverse events." data-id="CD007373-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Lidocaine 4% gel 8.5 mL versus placebo, Outcome 5 Side effects or adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo, Outcome 1 Mean pain score for tenaculum use." data-id="CD007373-fig-0029" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo, Outcome 1 Mean pain score for tenaculum use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo, Outcome 2 Mean pain score immediately after IUD insertion and tube removal." data-id="CD007373-fig-0030" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo, Outcome 2 Mean pain score immediately after IUD insertion and tube removal. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 1 Mean pain score at tenaculum placement." data-id="CD007373-fig-0031" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 1 Mean pain score at tenaculum placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 2 Mean pain score with IUD insertion." data-id="CD007373-fig-0032" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 2 Mean pain score with IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 3 Mean global pain score at end of visit." data-id="CD007373-fig-0033" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 3 Mean global pain score at end of visit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0034"> <p> <div class="table" id="CD007373-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No NSAID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nelson 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Overall</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nelson 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lidocaine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nelson 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Saline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (a versus b)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Lidocaine 2% 1.2 mL versus placebo, Outcome 4 Mean pain scores by NSAID intake. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0034">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0035"> <p> <div class="table" id="CD007373-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine<br/> (N = 100)<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (N = 100)<br/> Median (range)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aksoy 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>During IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0 to 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00 (0 to 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.001</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Lidocaine 10% spray, 40 mg, versus placebo, Outcome 1 Median pain scores.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0035">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0036"> <p> <div class="table" id="CD007373-tblf-0010"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period and scale</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine 1% paracervical block</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (saline injection)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>VAS 0 to 10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (range 0 to 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 (range 4 to 9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 (range 5 to 8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 (range 0 to 5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (range 2 to 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 (range 3 to 7)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 min after procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (range 0 to 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (range 1 to 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4 (range 1 to 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mody 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Scale 0 to 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mody 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At tenaculum placement</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 (1st, 3rd quartiles: 4, 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 (1st, 3rd quartiles: 14.5, 40.5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.008</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mody 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 (1st, 3rd quartiles: 3, 73)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62 (1st, 3rd quartiles: 8, 77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.09</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mody 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 min after procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 (1st, 3rd quartiles: 2, 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17 (1st, 3rd quartiles: 3, 35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Lidocaine 1% 10 mL paracervical block versus no paracervical block, Outcome 1 Median pain scores. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0036">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Lidocaine 1% 10 mL paracervical block versus no paracervical block, Outcome 2 Side effects or adverse events." data-id="CD007373-fig-0037" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Lidocaine 1% 10 mL paracervical block versus no paracervical block, Outcome 2 Side effects or adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0038"> <p> <div class="table" id="CD007373-tblf-0011"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lidocaine 1%<br/> paracervical block</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (saline 0.9% injection)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control<br/> (no intervention)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cırık 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Lidocaine 1% 10 mL paracervical block versus no paracervical block, Outcome 3 Vasovagal syncope. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0038">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 1 Mean pain scores after IUD insertion." data-id="CD007373-fig-0039" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 1 Mean pain scores after IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 2 Moderate or severe pain (from VAS)." data-id="CD007373-fig-0040" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 2 Moderate or severe pain (from VAS). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 3 Satisfaction or acceptability." data-id="CD007373-fig-0041" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg, Outcome 3 Satisfaction or acceptability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0042"> <p> <div class="table" id="CD007373-tblf-0012"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Misoprostol + diclofenac</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Diclofenac</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibrahim 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 (range 2.5 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5 (range 0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ibrahim 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sääv 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7 (range 2.5 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5 (range 0 to 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sääv 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N = 30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone, Outcome 1 Median pain score at IUD insertion. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0042">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone, Outcome 2 Side effects or adverse events." data-id="CD007373-fig-0043" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone, Outcome 2 Side effects or adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone, Outcome 3 Satisfaction or acceptability." data-id="CD007373-fig-0044" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone, Outcome 3 Satisfaction or acceptability. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 1 Mean pain score with tenaculum placement." data-id="CD007373-fig-0045" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 1 Mean pain score with tenaculum placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 2 Mean pain score during IUD insertion." data-id="CD007373-fig-0046" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 2 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 3 Mean pain score during IUD insertion by parity." data-id="CD007373-fig-0047" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 3 Mean pain score during IUD insertion by parity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 4 Mean pain scores post IUD insertion." data-id="CD007373-fig-0048" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 4 Mean pain scores post IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0049"> <p> <div class="table" id="CD007373-tblf-0013"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time frame</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Misoprostol<br/> (N = 37)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (N = 36)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lathrop 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immediately after insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46 (range 11 to 92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 (range 0 to 90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.044</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lathrop 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Before discharge from clinic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.5 (range 1 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.5 (range 0 to 86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.024</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 5 Median pain scores.</p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0049">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 6 Moderate to severe pain (removal of first IUC and insertion of LNG‐IUS." data-id="CD007373-fig-0050" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.6</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 6 Moderate to severe pain (removal of first IUC and insertion of LNG‐IUS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 7 Moderate to severe pain at IUD insertion." data-id="CD007373-fig-0051" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.7</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 7 Moderate to severe pain at IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 8 Side effects or adverse events." data-id="CD007373-fig-0052" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.8</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 8 Side effects or adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-018-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-018-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Misoprostol 400 μg versus placebo, Outcome 9 Satisfaction or acceptability." data-id="CD007373-fig-0053" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.9</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 9 Satisfaction or acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-018-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0054"> <p> <div class="table" id="CD007373-tblf-0014"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Reported P</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Espey 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pain would not influence future IUD use (at 1 to 2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&gt; 0.99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Espey 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfied or very satisfied with using IUD (at 1 to 2 weeks)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lotke 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfied or very satisfied with their IUD (at 1 week)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lotke 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Would definitely recommend IUD to a friend (at 1 month)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.10</div> <div class="figure-caption"> <p>Comparison 18 Misoprostol 400 μg versus placebo, Outcome 10 Satisfaction or acceptability (1 week later). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0054">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Nitric oxide donors versus placebo, Outcome 1 Mean pain score at tenaculum placement." data-id="CD007373-fig-0055" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Nitric oxide donors versus placebo, Outcome 1 Mean pain score at tenaculum placement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Nitric oxide donors versus placebo, Outcome 2 Mean pain score during IUD insertion." data-id="CD007373-fig-0056" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Nitric oxide donors versus placebo, Outcome 2 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Nitric oxide donors versus placebo, Outcome 3 Mean pain score 30 minutes post IUD insertion." data-id="CD007373-fig-0057" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Nitric oxide donors versus placebo, Outcome 3 Mean pain score 30 minutes post IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Nitric oxide donors versus placebo, Outcome 4 Satisfaction." data-id="CD007373-fig-0058" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 Nitric oxide donors versus placebo, Outcome 4 Satisfaction.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Tramadol 50 mg versus naproxen 550 mg, Outcome 1 Mean pain score during IUD insertion." data-id="CD007373-fig-0059" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Tramadol 50 mg versus naproxen 550 mg, Outcome 1 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Tramadol 50 mg versus naproxen 550 mg, Outcome 2 Satisfaction or acceptability." data-id="CD007373-fig-0060" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Tramadol 50 mg versus naproxen 550 mg, Outcome 2 Satisfaction or acceptability.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Lavender scent versus placebo, Outcome 1 Participants reporting medium or severe pain with IUD insertion." data-id="CD007373-fig-0061" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Lavender scent versus placebo, Outcome 1 Participants reporting medium or severe pain with IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007373-fig-0062"> <p> <div class="table" id="CD007373-tblf-0015"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lavender<br/> (N = 53)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Placebo<br/> (N = 53)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Shahnazi 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (1st, 3rd quartiles: 0, 3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 (1st, 3rd quartiles: 0, 3)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Lavender scent versus placebo, Outcome 2 Median pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0062">Navigate to figure in review</a></div> </div> <div class="figure" id="CD007373-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/urn:x-wiley:14651858:media:CD007373:CD007373-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_t/tCD007373-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Emptying of bladder: delayed versus immediate, Outcome 1 Mean pain score during IUD insertion." data-id="CD007373-fig-0063" src="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Emptying of bladder: delayed versus immediate, Outcome 1 Mean pain score during IUD insertion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/media/CDSR/CD007373/image_n/nCD007373-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007373-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: lidocaine 2% gel</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Lidocaine 2% gel compared with placebo for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: lidocaine 2% gel, topical</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on parity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at tenaculum placement</b> (10 cm or 100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.03 (‐0.25 to 0.18)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>345<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No limitation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10 cm or 100 mm VAS) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.02 (‐0.21 to 0.18)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>409<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No limitation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; SMD: Standardized mean difference; CI: Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Summary of findings: lidocaine 2% gel</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007373-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: other lidocaine</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Lidocaine formulations for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: lidocaine formulations (see Notes)</b> </p> <p><b>Comparison: see Notes</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on intervention<br/> (parity specification)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at tenaculum placement</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><i>Median (1st, 3rd quartiles):</i> </p> <p>12 (4, 27) vs 28 (14.5, 40.5)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50<br/> (<a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 1% paracervical block vs no intervention</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion</b> (10 cm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.96 (95% CI ‐3.00 to ‐0.92)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>92<br/> (<a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) vs placebo cream</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion</b> (10 cm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>1.00 (0 to 6) vs 3.00 (0 to 7)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200<br/> (<a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 10% spray vs saline placebo</p> <p>(parous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for IUC insertion (within 10 min)</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐15.90 (95% CI ‐22.77 to ‐9.03)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>209</p> <p>(<a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 4% short‐acting gel vs placebo gel</p> <p>(nulliparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at 30 min post‐insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐11.10 (95% CI ‐19.05 to ‐3.15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>114</p> <p>(<a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine 4% short‐acting gel vs placebo gel</p> <p>(nulliparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; MD: Mean difference; CI: Confidence interval </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Summary of findings: other lidocaine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007373-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings: naproxen or tramadol</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Naproxen or tramadol for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: naproxen or tramadol</b> </p> <p><b>Comparison: see Notes</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on intervention<br/> (parity)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.63 (‐0.94 to ‐0.32)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>69</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tramadol 50 mg vs naproxen 550 mg</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (10‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.94 (‐2.35 to ‐1.53)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction</b> : <b>insertion experience was unpleasant</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.02 (0.01 to 0.09)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction</b> : <b>would not want treatment in future</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.02 (0.00 to 0.08)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68</p> <p>(<a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg vs placebo</p> <p>(multiparous)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score 1 hour after IUC insertion</b> (5‐point scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐1.04 (‐1.67 to ‐0.41)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50</p> <p>(<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (4 doses) vs placebo; both had paracervical block</p> <p>(48 nulliparous/50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score 2 hours after IUC insertion</b> (5‐point scale) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.98 (‐1.64 to ‐0.32)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41</p> <p>(<a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naproxen 300 mg (4 doses) vs placebo; both had paracervical block</p> <p>(48 nulliparous/50)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; MD: Mean difference; CI: Confidence interval: OR: Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Summary of findings: naproxen or tramadol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007373-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings: misoprostol 400 µg</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Misoprostol 400 µg compared with placebo for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: misoprostol 400 µg</b> </p> <p><b>Comparison: placebo</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on administration<br/> (parity)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score during IUC insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>SMD 0.27 (95% CI 0.07 to 0.46)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>400<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal<br/> (parity varied by trial) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: cramping</b> (before IUC insertion) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>OR 2.64 (95% CI 1.46 to 4.76)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>466<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal<br/> (parity varied by trial) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Moderate to severe pain at IUC insertion</b> (dichotomous) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.30 (95% CI 0.16 to 0.55)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>179<br/> (<a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> <p>(nulligravida)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Satisfaction: experience was</b> </p> <p><b>slightly or not disagreeable</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>OR 4.34 (95% CI 2.32 to 8.12)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>179<br/> (<a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> <p>(nulligravida)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score at IUC insertion</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>46 (11 to 92) vs 34 (0 to 90)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73</p> <p>(<a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> <p>(no pregnancy &gt;= 20 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score before leaving clinic</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><i>Median (range):</i> </p> <p>35.5 (1 to 100) vs 20.5 (0 to 86)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>73</p> <p>(<a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> <p>(no pregnancy &gt;= 20 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain score for highest level before leaving clinic</b> (100 mm VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 7.60 (95% CI 6.48 to 8.72)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105<br/> (<a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> <p>(no pregnancy &gt;= 14 weeks)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: VAS: visual analog scale; SMD: Standardized mean difference; MD: Mean difference; CI: Confidence interval; OR<b>:</b> Odds Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Summary of findings: misoprostol 400 µg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD007373-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings: misoprostol 400 µg + diclofenac</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Misoprostol 400 µg + diclofenac compared with diclofenac for pain with IUC insertion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population: women with IUC being inserted</b> </p> <p><b>Settings: clinic</b> </p> <p><b>Intervention: misoprostol 400 µg (sublingual) + diclofenac 100 mg</b> </p> <p><b>Comparison: diclofenac 100 mg</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Relative effect (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Quality of evidence<sup>a</sup> <br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Notes on parity</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: headache</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.68 (1.23 to 26.19)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: abdominal pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 3.93 (1.41 to 10.97)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>230</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effect: shivering</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 5.48 (1.41 to 21.33)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79</p> <p>(<a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction: would choose treatment again</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.30 (0.14 to 0.65)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction: would recommend treatment to friend</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>OR 0.36 (0.16 to 0.81)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255</p> <p>(<a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean only</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>IUC: intrauterine contraception: CI: Confidence interval; OR<b>:</b> Odds Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>When the evidence came from only one trial, we downgraded one level; further research may change the estimate. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Summary of findings: misoprostol 400 µg + diclofenac</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007373-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intervention summary</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Timing before procedure</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Parity</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg x 4 doses (+ paracervical block, 1% lidocaine, 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo (+ paracervical block, 1% lidocaine, 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Previous night and 1.5 h prior;<br/> 2 and 6 h after </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(96% nulliparous)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>≥ 45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 to 4 h<br/> (also 4 to 6 h after) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 to 45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(Requesting abortion)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2% gel (amount unspecified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lubricant gel or<br/> no intervention </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 1 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>prior to uterine sounding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each, via syringe</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomization stratified by parity</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Parous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo cream</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab on cervix and cervical opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No analgesia (no intervention)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Saline or no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 min (lidocaine); 1 h (ibuprofen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous or no vaginal delivery</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prior cesarean delivery only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pregnancy &gt; 19 6/7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 to 8 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 to 4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No pregnancy &gt; 13 6/7 weeks</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulligravida</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>immediately prior</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo ointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>35 to 40 min</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nulliparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 h</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiparous</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 min (also during)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bladder emptying delayed (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bladder emptying immediate (before IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Water 1L, orally, 1 h before appointment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>No full report; sources included conference abstract and clinical trial listing </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Intervention summary</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007373-tbl-0007"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome summary: pain</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total N</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain at tenaculum placement</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain during IUC insertion</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pain after IUC insertion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (x 4 doses) + paracervical block (1% lidocaine 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen &lt; placebo (1 h, 2 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (4 to 6 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac &lt; placebo (5 min, 15 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (global, visit end)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (within 10 min)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (30 min);</p> <p>NS (1 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA &lt; placebo (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo<br/> or control </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo or control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lidocaine &lt; placebo or control (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (2 h, 6 h)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (5 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo (before clinic departure)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (immediately after)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (before clinic discharge)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo (before leaving clinic)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &lt; placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (30 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS (30 min)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol &lt; naproxen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Delayed bladder emptying (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral (water 1 L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>NS = no significant difference between study arms<br/> <sup>b</sup>Excluded from sensitivity analysis due to insufficient outcome data or low quality evidence </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Outcome summary: pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007373-tbl-0008"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome summary: side effects and satisfaction</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Study</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>N</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Experimental intervention</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Delivery</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Side effects or adverse events</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Satisfaction or acceptability</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>NSAID</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 550 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unsatisfied: naproxen &lt; placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0014" title="HubacherD , ReyesV , LilloS , ZepedaA , ChenP , CroxattoH . Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. American Journal of Obstetrics and Gynecology2006;195(5):1272‐7. ">Hubacher 2006</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 400 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0016" title="JensenHH , BlaabjergJ , LyndrupJ . Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskrift for Laeger1998;160(48):6958‐61. ">Jensen 1998</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 600 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0005" title="BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT . Immediate versus delayed IUD insertion after uterine aspiration. New England Journal of Medicine2011;364(23):2208‐17. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , JensenJT , Post‐Aspiration IUD Randomization (PAIR) Study Trial Group. Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception2015;91(3):193‐7. BednarekPH , CreininMD , ReevesMF , CwiakC , EspeyE , MayoJ , et al. Pain with IUD insertion following prophylactic ibuprofen: A randomized trial (abstract). Contraception2010;82(2):194‐5. ">Bednarek 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0008" title="ChorJ , Bregand‐WhiteJ , GolobofA , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial. Contraception2012;85(6):558‐62. ChorJ , HarwoodB , CowettA . Ibuprofen prophylaxis for levonorgestrel‐releasing intrauterine system insertion: A randomized controlled trial (abstract). Contraception2010;82(2):201‐2. ">Chor 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ibuprofen 800 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0021" title="MasseySE , VaradyJC , HenzlMR . Pain relief with naproxen following insertion of an intrauterine device. Journal of Reproductive Medicine1974;13(6):226‐31. ">Massey 1974</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Naproxen 300 mg (x 4 doses) + paracervical block (1% lidocaine 8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tablet, oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0027" title="ModyS . Pain control for intrauterine device placement: a Ttial of ketorolac prior to intrauterine device placement. clinicaltrials.gov/show/NCT01664559 (accessed 11 September 2014). [NCT01664559] NgoL , WardK , ModyS . Pain control for intrauterine device insertion: a randomized double‐blind controlled trial of ketorolac (abstract). Contraception2014;90(3):297. ">Ngo 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ketorolac 30 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intramuscular injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Lidocaine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0020" title="MaguireK , DavisA , Rosario TejedaL , WesthoffC . Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception2012;86(3):214‐9. MaguireK , DavisA , Rosario TejedaL , WesthoffCL . Intracervical 2% lidocaine gel as an analgesic during intrauterine device insertion: A randomized controlled trial (abstract). Contraception2012;85(3):324. MaguireK , MorrellK , WesthoffC , DavisA . Accuracy of providers' assessment of pain during intrauterine device insertion. Contraception2014;89(1):22‐4. ">Maguire 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (1 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0025" title="Mohammad‐Alizadeh‐CharandabiS , SeidiS , KazemiF . Effect of lidocaine gel on pain from copper IUD insertion: a randomized double‐blind controlled trial. Indian Journal of Medical Sciences2010;64(8):349‐55. ">Mohammad‐Alizadeh‐C 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0003" title="AllenRH , RakerC , GoyalV . Higher dose cervical 2% lidocaine gel for IUD insertion: A randomized controlled trial. Contraception2013; Vol. 88, issue 6:730‐6. ">Allen 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (6 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 3 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0026" title="NelsonAL , FongJK . Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception2013;88(1):37‐40. ">Nelson 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% (1.2 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Infused, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0022" title="McNicholasC , MaddenT , ZhaoQ , SecuraG , AllsworthJ , PeipertJ . Cervical lidocaine for IUD insertional pain: A randomized control trial (abstract). Contraception2012;86(3):319. McNicholasCP , MaddenT , ZhaoQ , SecuraG , AllsworthJE , PeipertJF . Cervical lidocaine for IUD insertional pain: a randomized controlled trial. American Journal of Obstetrics and Gynecology2012;207(5):384.e1‐6. ">McNicholas 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (2.5 to 4 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.5 to 1 mL Topical; 2 to 3 mL inserted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0028" title="RapkinRB . Self‐administered intravaginal 2% lidocaine gel prior to intrauterine device insertion in nulliparous women (LIVIIN). clinicaltrials.gov/show/NCT01534520 (accessed 4 September 2014). RapkinRB , AchillesSL , BoraasC , CremerM , SchwarzEB , ChenBA . Self‐administered lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial (abstract). Obstetrics and Gynecology2014;123(5 (Suppl)):110S. [NCT01534520] ">Rapkin 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% gel (5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Self‐inserted vaginally</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0033" title="Pharmanest AB2013 . A randomized, double blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study. www.clinicaltrialsregister.eu/ctr‐search/trial/2011‐006220‐20/SE (accessed 22 January 2015). TingakerB , BrodinA , IrestedtL , Ekman‐OrdebergG . A novel mucosal pain relief drug candidate ‐ SHACT ‐‐ gives highly significant analgesia at insertion of intra uterine device (IUD) (abstract). Reproductive Sciences2014;21(3):318A. Tornblom‐PaulanderS , TingåkerBK , WernerA , LiliecreutzC , ConnerP , WesselH , et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo‐controlled trial. Fertility and Sterility2015;103(2):422‐7. ">Tornblom‐Paulander 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4% gel (8.5 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 3 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0002" title="AcmazG . Lidocaine 10% spray reduces pain during intrauterine device insertion. clinicaltrials.gov/ct2/show/NCT02020551 (accessed 11 September 2014). AksoyH , AksoyÜ , OzyurtS , AçmazG , BabayigitM . Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double‐blind randomised controlled trial. Journal of Family Planning and Reproductive Health Care 2015 Mar 10 [Epub ahead of print]:1‐5. ">Aksoy 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10% spray (40 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical, 2 sites; 4 puffs total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0001" title="Ahmadi DoulabiM , TavakolianS , MortazaviA , Akbarzade BaghbanA . Effect of EMLA cream on pain of Copper IUD insertion [article in Persian]. Scientific Journal of Hamadan Nursing &amp; Midwifery Faculty2013;21(3):24‐30. AhmadiM . A comparison of EMLA cream and placebo on pain during IUD insertion in women referred to health centers of Imam Hussein. www.irct.ir/searchresult.php?id=5698&amp;number=4 (accessed 23 September 2014). [IRCT201209015698N4] TavakolianS , GhorbaniM , DoulabiMA , BaghbanAA , MortazaviA . Lidocaine‐prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Global Journal of Health Science2015;7(4):399‐404. ">Ahmadi Doulabi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EMLA cream 5% (lidocaine + prilocaine) (5 g)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Swab</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0024" title="KrishnanS , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block (abstract). Contraception2011;84(3):319. ModySK , KileyJ , RademakerA , GawronL , StikaC , HammondC . Pain control for intrauterine device insertion: A randomized trial of 1% lidocaine paracervical block. Contraception2012;86(6):704‐9. ">Mody 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0009" title="CırıkDA , TaşkınEF , TuğluA , OrtaçAS , DaiO . Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single‐blinded, controlled study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology2013;2(3):263‐7. ">Cırık 2013</a><sup>b</sup> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1% paracervical block (10 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 sites, 5 mL each</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0007" title="CastroTV , FranceschiniSA , Poli‐NetoO , FerrianiRA , Silva de SaMF , VieiraCS . Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel‐releasing intrauterine system in women without previous vaginal delivery: a RCT. Human Reproduction2014;29(11):2439‐45. VittiT , FerrianiR , VieiraC . Local anaesthetic in uterine cervix is not associated with lower pain score in levonorgestrel‐releasing intrauterine system insertion in women without previous vaginal delivery (abstract). European Journal of Contraception and Reproductive Health Care2012;17(S1):S104. ">Castro 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2% intracervical block (1.8 mL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 sites</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Misoprostol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0029" title="SäävI , AronssonA , MarionsL , StephanssonO , Gemzell‐DanielssonK . Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Human Reproduction2007;22(10):2647‐52. ">Sääv 2007</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Shivering: misoprostol &gt; placebo;<br/> Other: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0015" title="IbrahimZM , Sayed AhmedWA . Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. European Journal of Contraception and Reproductive Health Care2013;18(4):300‐8. ">Ibrahim 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg + diclofenac</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Headache or abdominal pain: misoprostol &gt; placebo;<br/> Other: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Choose again or recommend to friend: misoprostol &lt; control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0013" title="Gemzell‐DanielssonK , InkiP , BoubliL , O'FlynnM , KunzM , HeikinheimoO . Bleeding pattern and safety of consecutive use of the levonorgestrel‐releasing intrauterine system (LNG‐IUS)‐‐a multicentre prospective study. Human Reproduction2010;25(2):354‐9. HeikinheimoO , InkiP , KunzM , ParmhedS , AnttilaAM , OlssonSE , et al. Double‐blind, randomized, placebo‐controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel‐releasing intrauterine system. Contraception2010;81(6):481‐6. ">Heikinheimo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Sublingual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0011" title="EdelmanAB , SchaeferE , OlsonA , VanHoutenL , BednarekP , LeclairC , et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception2011;84(3):234‐9. ">Edelman 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0018" title="LathropE , HaddadL , McWhorterCP , GoedkenP . Self‐administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception2013;88(6):725‐9. ">Lathrop 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0012" title="EspeyE , LeemanL , GreeneH , SinghR , OgburnT , FowlerK . Misoprostol for IUD insertion in nulliparous women: A randomized controlled trial (abstract). Contraception2013;88(3):456‐7. EspeyE , SinghRH , LeemanL , OgburnT , FowlerK , GreeneH . Misoprostol for intrauterine device insertion in nulliparous women: A randomized controlled trial. American Journal of Obstetrics and Gynecology2014;210(3):208.e1‐5. ">Espey 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 µg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0019" title="LotkeP . Use of misoprostol for intrauterine device (IUD) insertion in nulliparous women. clinicaltrials.gov/show/NCT01001897 (accessed 28 October 2014). LotkePS , TiwariA , NuñoVL . Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. American Journal of Clinical and Experimental Obstetrics Gynecology2013;1(1):62‐8. ">Lotke 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0032" title="SwensonC , TurokDK , WardK , JacobsonJC , DermishA . Self‐administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstetrics and Gynecology2012;120(2 Part 1):341‐7. ">Swenson 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal or buccal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0010" title="DijkhuizenK , DekkersOM , HolleboomCA , DeGrootCJ , HellebrekersBW , VanRoosmalenGJ , et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Human Reproduction2011;26(2):323‐9. ">Dijkhuizen 2011</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0030" title="ScavuzziA , SouzaAS , CostaAA , AmorimMM . Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Human Reproduction2013;28(8):2118‐25. ">Scavuzzi 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 μg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Vaginal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Misoprostol &gt; placebo</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0004" title="BednarekPH , MicksEA , EdelmanAB , LiH , JensenJT . The effect of nitroprusside on IUD insertion experience in nulliparous women: A pilot study. Contraception2013;87(4):421‐5. ">Bednarek 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroprusside gel 1%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with pain control: NS;<br/> Satisfaction with procedure: nitroprusside &lt; placebo </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0023" title="MicksEA , JensenJT , BednarekPH . The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception2014;90(1):60‐5. ">Micks 2014</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Nitroglycerin ointment 0.5 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 mL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with pain control or procedure: NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007373-bbs2-0017" title="KarabayirliS , AyrimAA , MusluB . Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. Journal of Minimally Invasive Gynecology2012;19(5):581‐4. ">Karabayirli 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tramadol 50 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0031" title="ShahnaziM , NikjooR , YavarikiaP , Mohammad‐Alizadeh‐CharandabiS . Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. Journal of Caring Sciences2012;1(4):255‐61. ">Shahnazi 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lavender 10 drops in diluted milk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 drops on cotton, inhaled</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007373-bbs2-0006" title="CameronST , GlasierA , CooperA , JohnstoneA . Does a full bladder assist insertion of intrauterine contraception?: a randomised trial. Journal of Family Planning and Reproductive Health Care2013;39(3):207‐10. ">Cameron 2013</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Delayed bladder emptying (after IUC insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral (water 1 L)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>_</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>NA = not available (assessed but not reported, or provided insufficient data)<br/> <sup>b</sup>Excluded from sensitivity analysis due to low quality evidence<br/> <sup>c</sup>NS = no significant difference between study arms </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Outcome summary: side effects and satisfaction</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/full#CD007373-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain scores during and immediately after IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Pain during IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.72, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Pain immediately after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.93, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain scores after IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Mean pain score 1 hour after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐1.67, ‐0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Mean pain score 2 hours after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.98 [‐1.64, ‐0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Mean pain score 3 hours after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.14, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Mean pain score 4 hours after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.35 [‐0.98, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Mean pain score 5 hours after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.69, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Mean pain score 6 hours after IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.56, 0.64]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Naproxen 300 mg (x 4 doses) + paracervical block versus placebo plus paracervical block</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Naproxen 550 mg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.94 [‐2.35, ‐1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Rated insertion unpleasant or very unpleasant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.01, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Would not prefer the medication for future IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Naproxen 550 mg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ibuprofen 400 mg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Ibuprofen 400 mg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ibuprofen 600 mg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Reported moderate to severe pain during IUD insertion (3 or greater on the 1 to 10 scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.67, 5.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Ibuprofen 600 mg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Ibuprofen 800 mg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score at tenaculum placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐1.24, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score at IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [‐0.98, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Median pain score at IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Ibuprofen 800 mg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Ketorolac 30 mg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Ketorolac 30 mg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Lidocaine 2% versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score at tenaculum placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.25, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.21, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Lidocaine 2% versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lidocaine 2% gel 6 mL versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score 20 minutes post‐insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐8.81, 7.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Side effects or adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Moderate or severe nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Moderately or severely dizzy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.07, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Amount of pain was mostly or completely acceptable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.50, 2.25]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lidocaine 2% gel 6 mL versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Lidocaine 2% gel versus no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.24, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Lidocaine 2% gel versus no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Lidocaine 2% gel, 2.5 to 5 mL, versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Median pain scores by parity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Median difference in pain scores from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Lidocaine 2% gel, 2.5 to 5 mL, versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Lidocaine 4% gel 8.5 mL versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score for IUD insertion (within 10 min of insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.90 [‐22.77, ‐9.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score 30 min post‐insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.10 [‐19.05, ‐3.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean pain score 1 h post‐insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐6.79, 4.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Additional analgesic at clinic <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.21, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Side effects or adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Any adverse event</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.46, 1.46]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Lidocaine 4% gel 8.5 mL versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score for tenaculum use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.78 [‐3.66, ‐1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score immediately after IUD insertion and tube removal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.96 [‐1.00, ‐0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">EMLA cream 5% (25 mg lidocaine + 25 mg prilocaine) versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Lidocaine 2% 1.2 mL versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score at tenaculum placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐1.88, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score with IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.73 [‐2.38, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean global pain score at end of visit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.82, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mean pain scores by NSAID intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Lidocaine 2% 1.2 mL versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Lidocaine 10% spray, 40 mg, versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Lidocaine 10% spray, 40 mg, versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Lidocaine 1% 10 mL paracervical block versus no paracervical block</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Side effects or adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vasovagal symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.30 [0.36, 149.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.37, 6.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vasovagal syncope <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Lidocaine 1% 10 mL paracervical block versus no paracervical block</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain scores after IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Two hours after</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.90 [‐2.36, 18.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Six hours after</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.5 [‐5.47, 12.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Moderate or severe pain (from VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.26, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.35, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Experience was uncomfortable or very uncomfortable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.35, 1.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Lidocaine 2% 1.8 mL injected versus ibuprofen 400 mg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Median pain score at IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Side effects or adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.68 [1.23, 26.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Abdominal pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.93 [1.41, 10.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.98 [0.29, 13.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Any side effect</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.72, 4.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Shivering</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.48 [1.41, 21.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 Diarrhea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.52 [0.84, 7.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.11 [0.18, 24.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Overall very satisfied or satisfied</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.05, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Would choose treatment again</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.14, 0.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Would recommend treatment to a friend</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.16, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Rated insertion experience as 'very little unpleasant'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.13, 1.66]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Misoprostol 400 µg + diclofenac 100 mg versus diclofenac 100 mg alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Misoprostol 400 μg versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score with tenaculum placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐16.05, 14.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.07, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean pain score during IUD insertion by parity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.04, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nulliparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.20, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Multiparous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐0.11, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Mean pain scores post IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Mean pain score 5 min post‐insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐14.02, 14.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Highest pain level (immediately after insertion)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.97, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Pain before discharge from clinic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.67, 0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Highest pain level before discharge from clinic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.60 [6.48, 8.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Median pain scores <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Moderate to severe pain (removal of first IUC and insertion of LNG‐IUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.57, 5.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Moderate to severe pain at IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.16, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Side effects or adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Any complication</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.59, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Vasovagal</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.64, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Any side effect</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.62 [0.77, 16.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Cramping</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.64 [1.46, 4.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.63, 3.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [0.74, 7.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.7 Bleeding</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.06, 18.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8 Lightheaded</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.36 [0.13, 88.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9 Hypoesthesia oral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>13.29 [0.71, 247.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.10 Oral pain</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.11 [1.06, 345.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.11 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.81 [0.53, 14.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.12 Diarrhea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.16, 16.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.13 Fevers and Chills</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.27 [1.02, 27.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Rated insertion experience as slightly or not disagreeable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.34 [2.32, 8.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Satisfied or very satisfied (1 week later)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.28, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Likely or very likely to have future IUD insertion (1 week later)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.49, 3.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 Would recommend IUD to a friend (1 week later)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.22, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Satisfaction or acceptability (1 week later) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Misoprostol 400 μg versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Nitric oxide donors versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score at tenaculum placement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.0 [‐32.09, 12.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.80 [‐21.19, 7.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Mean pain score 30 minutes post IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.0 [‐35.42, 9.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Mean score for satisfaction with pain control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.39 [‐24.55, 7.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Mean score for overall satisfaction with procedure</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.53 [‐19.80, 6.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Nitric oxide donors versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Tramadol 50 mg versus naproxen 550 mg</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.63 [‐0.94, ‐0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Satisfaction or acceptability <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Rated insertion experience as unpleasant or very unpleasant</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.06, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Would not prefer the medication for future IUD insertion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.02, 2.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Tramadol 50 mg versus naproxen 550 mg</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0028">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0029"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Lavender scent versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Participants reporting medium or severe pain with IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.27, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Median pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Lavender scent versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0029">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007373-tbl-0030"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Emptying of bladder: delayed versus immediate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mean pain score during IUD insertion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐1.24, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Emptying of bladder: delayed versus immediate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007373.pub3/references#CD007373-tbl-0030">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007373.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007373-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007373-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD007373-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007373\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007373\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007373\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007373\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007373\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=gpg7sF9V&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007373.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007373.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007373.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007373.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007373.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719571803"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007373.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719571807"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007373.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918debfffca89373',t:'MTc0MDcxOTU3Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 